<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="F" Type="Primary">Pharmacy</JournalSubject>
        <JournalSubject Code="F00008" Priority="1" Type="Secondary">Pharmacy</JournalSubject>
        <JournalSubject Code="B21007" Priority="2" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="C12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>1</IssueIDStart>
          <IssueIDEnd>1</IssueIDEnd>
          <IssueArticleCount>25</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2005</Year>
              <Month>3</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2005</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art9">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>71061</ArticleID>
            <ArticleDOI>10.1208/aapsj070109</ArticleDOI>
            <ArticleSequenceNumber>9</ArticleSequenceNumber>
            <ArticleTitle Language="En">DNA-based therapeutics and DNA delivery systems: A comprehensive review</ArticleTitle>
            <ArticleFirstPage>E61</ArticleFirstPage>
            <ArticleLastPage>E77</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>28</Day>
              </RegistrationDate>
              <Received>
                <Year>2004</Year>
                <Month>2</Month>
                <Day>6</Day>
              </Received>
              <Accepted>
                <Year>2004</Year>
                <Month>4</Month>
                <Day>8</Day>
              </Accepted>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>1</IssueIDStart>
              <IssueIDEnd>1</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Siddhesh</GivenName>
                  <GivenName>D.</GivenName>
                  <FamilyName>Patil</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>David</GivenName>
                  <GivenName>G.</GivenName>
                  <FamilyName>Rhodes</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Diane</GivenName>
                  <GivenName>J.</GivenName>
                  <FamilyName>Burgess</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>860-486-3760</Phone>
                  <Fax>860-486-4998</Fax>
                  <Email>Diane.burgess@uconn.edu</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>Department of Pharmaceutical Sciences</OrgDivision>
                <OrgName>University of Connecticut</OrgName>
                <OrgAddress>
                  <Postcode>06269</Postcode>
                  <City>Storrs</City>
                  <State>CT</State>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>The past several years have witnessed the evolution of gene medicine from an experimental technology into a viable strategy for developing therapeutics for a wide range of human disorders. Numerous prototype DNA-based biopharmaceuticals can now control disease progression by induction and/or inhibition of genes. These potent therapeutics include plasmids containing transgenes, oligonucleotides, aptamers, ribozymes, DNAzymes, and small interfering RNAs. Although only 2 DNA-based pharmaceuticals (an antisense oligonucleotide formulation, Vitravene, (USA, 1998), and an adenoviral gene therapy treatment, Gendicine (China, 2003), have received approval from regulatory agencies; numerous candidates are in advanced stages of human clinical trials. Selection of drugs on the basis of DNA sequence and structure has a reduced potential for toxicity, should result in fewer side effects, and therefore should eventually yield safer drugs than those currently available. These predictions are based on the high selectivity and specificity of such molecules for recognition of their molecular targets. However, poor cellular uptake and rapid in vivo degradation of DNA-based therapeutics necessitate the use of delivery systems to facilitate cellular internalization and preserve their activity. This review discusses the basis of structural design, mode of action, and applications of DNA-based therapeutics. The mechanisms of cellular uptake and intracellular trafficking of DNA-based therapeutics are examined, and the constraints these transport processes impose on the choice of delivery systems are summarized. Finally, the development of some of the most promising currently available DNA delivery platforms is discussed, and the merits and drawbacks of each approach are evaluated.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>nucleic acid therapeutics</Keyword>
              <Keyword>DNA delivery systems</Keyword>
              <Keyword>nonviral vectors</Keyword>
              <Keyword>viral vectors</Keyword>
              <Keyword>liposomes</Keyword>
              <Keyword>gene therapy</Keyword>
            </KeywordGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Published: April 8, 2005.</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_71061.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ST</Initials>
                    <FamilyName>Crooke</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">An overview of progress in antisense therapeutics</ArticleTitle>
                  <JournalTitle>Antisense Nucleic Acid Drug Dev</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>115</FirstPage>
                  <LastPage>122</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9593049</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXivFKgtL4%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1089/oli.1.1998.8.115</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Crooke ST. An overview of progress in antisense therapeutics.<Emphasis Type="Italic">Antisense Nucleic Acid Drug Dev</Emphasis>. 1998;8:115–122.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RA</Initials>
                    <FamilyName>Stull</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FC</Initials>
                    <FamilyName>Szoka</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects</ArticleTitle>
                  <JournalTitle>Pharm Res</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <FirstPage>465</FirstPage>
                  <LastPage>483</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7596980</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXltFaqsbg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1016281324761</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Stull RA, Szoka FC Jr. Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.<Emphasis Type="Italic">Pharm Res</Emphasis>. 1995;12:465–483.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SD</Initials>
                    <FamilyName>Patil</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DJ</Initials>
                    <FamilyName>Burgess</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">DNA-based Biopharmaceuticals: therapeutics for the 21st Century</ArticleTitle>
                  <JournalTitle>AAPS Newsmagazine</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <IssueID>12</IssueID>
                  <FirstPage>27</FirstPage>
                  <LastPage>27</LastPage>
                </BibArticle>
                <BibUnstructured>Patil SD, Burgess DJ. DNA-based Biopharmaceuticals: therapeutics for the 21st Century.<Emphasis Type="Italic">AAPS Newsmagazine</Emphasis> 2003;6(12):27.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BF</Initials>
                    <FamilyName>Baker</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">The role of antisense oligonucleotides in the wave of genomic information</ArticleTitle>
                  <JournalTitle>Nucleosides Nucleotides Acids</JournalTitle>
                  <VolumeID>20</VolumeID>
                  <IssueID>4–7</IssueID>
                  <FirstPage>397</FirstPage>
                  <LastPage>399</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXmslCru78%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1081/NCN-100002313</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Baker BF. The role of antisense oligonucleotides in the wave of genomic information.<Emphasis Type="Italic">Nucleosides Nucleotides Acids</Emphasis>, 2001;20(4–7):397–399.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GJB</Initials>
                    <FamilyName>Ommen</FamilyName>
                    <Particle>Van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Bakker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Dunnen</FamilyName>
                    <Particle>Den</Particle>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">The human genome project and the future of diagnostics, treatment, and prevention</ArticleTitle>
                  <JournalTitle>Lancet</JournalTitle>
                  <VolumeID>354</VolumeID>
                  <IssueID>suppl 1</IssueID>
                  <FirstPage>5</FirstPage>
                  <LastPage>10</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0140-6736(99)90241-6</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Van Ommen GJB, Bakker E, Den Dunnen JT. The human genome project and the future of diagnostics, treatment, and prevention.<Emphasis Type="Italic">Lancet</Emphasis>. 1999;354(suppl 1):5–10.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Uherek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Wels</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">DNA-carrier proteins for targeted gene delivery</ArticleTitle>
                  <JournalTitle>Adv Drug Deliv Rev</JournalTitle>
                  <VolumeID>44</VolumeID>
                  <IssueID>2–3</IssueID>
                  <FirstPage>153</FirstPage>
                  <LastPage>166</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11072112</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXovFGlsrY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0169-409X(00)00092-2</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Uherek C, Wels W. DNA-carrier proteins for targeted gene delivery.<Emphasis Type="Italic">Adv Drug Deliv Rev</Emphasis>. 2000;44(2–3):153–166.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Johnston</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Talaat</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>McGuire</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Genetic Immunization What's in a Name?</ArticleTitle>
                  <JournalTitle>Arch Med Res</JournalTitle>
                  <VolumeID>33</VolumeID>
                  <FirstPage>325</FirstPage>
                  <LastPage>329</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12234521</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XntVWgu7s%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0188-4409(02)00383-1</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Johnston SA, Talaat AM, McGuire MJ. Genetic Immunization What's in a Name?<Emphasis Type="Italic">Arch Med Res</Emphasis>. 2002;33:325–329.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>WA</Initials>
                    <FamilyName>Denny</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Prodrugs for gene-directed enzyme-prodrug therapy (suicide gene therapy)</ArticleTitle>
                  <JournalTitle>J Biomed Biotechnol</JournalTitle>
                  <VolumeID>1</VolumeID>
                  <FirstPage>48</FirstPage>
                  <LastPage>70</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1155/S1110724303209098</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Denny WA. Prodrugs for gene-directed enzyme-prodrug therapy (suicide gene therapy).<Emphasis Type="Italic">J Biomed Biotechnol</Emphasis>. 2003;1:48–70.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>WA</Initials>
                    <FamilyName>Denny</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WR</Initials>
                    <FamilyName>Wilson</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">The design of selectively-activated anti-cancer prodrugs for use in antibody-directed and gene-directed enzyme-prodrug therapies</ArticleTitle>
                  <JournalTitle>J Pharm Pharmacol</JournalTitle>
                  <VolumeID>50</VolumeID>
                  <FirstPage>387</FirstPage>
                  <LastPage>394</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9625483</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXjsVylsL8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Denny WA, Wilson WR. The design of selectively-activated anti-cancer prodrugs for use in antibody-directed and gene-directed enzyme-prodrug therapies.<Emphasis Type="Italic">J Pharm Pharmacol</Emphasis> 1998;50:387–394.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TA</Initials>
                    <FamilyName>Connors</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">The choice of prodrugs for gene directed enzyme produrg therapy of cancer</ArticleTitle>
                  <JournalTitle>Gene Ther</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <FirstPage>702</FirstPage>
                  <LastPage>709</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8750009</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXhtVSktr3I</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Connors TA. The choice of prodrugs for gene directed enzyme produrg therapy of cancer.<Emphasis Type="Italic">Gene Ther</Emphasis> 1995;2:702–709.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bentires-Alj</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A-C</Initials>
                    <FamilyName>Hellin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Lechanteur</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Cytosine deaminase suicide gene therapy for peritoneal carcinomatosis</ArticleTitle>
                  <JournalTitle>Cancer Gene Ther</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>20</FirstPage>
                  <LastPage>26</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10678352</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXhtF2ns7k%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.cgt.7700093</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bentires-Alj M, Hellin A-C, Lechanteur C, et al. Cytosine deaminase suicide gene therapy for peritoneal carcinomatosis.<Emphasis Type="Italic">Cancer Gene Ther</Emphasis>. 2000;7:20–26.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>WF</Initials>
                    <FamilyName>Anderson</FamilyName>
                  </BibAuthorName>
                  <Year>1984</Year>
                  <ArticleTitle Language="En">Prospects for human gene therapy</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>226</VolumeID>
                  <FirstPage>401</FirstPage>
                  <LastPage>409</LastPage>
                  <Occurrence Type="PID">
                    <Handle>6093246</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL2cXmt1emtLY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.6093246</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Anderson WF. Prospects for human gene therapy.<Emphasis Type="Italic">Science</Emphasis>. 1984;226:401–409.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HL</Initials>
                    <FamilyName>Fitzsimons</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Bland</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>During</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain</ArticleTitle>
                  <JournalTitle>Methods</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>227</FirstPage>
                  <LastPage>236</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12413421</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xot1Kms7Y%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S1046-2023(02)00227-X</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fitzsimons HL, Bland RJ, During MJ. Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain.<Emphasis Type="Italic">Methods</Emphasis>. 2002;28(2):227–236.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Walther</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Stein</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Cell type specific and inducible promoters for vectors in gene therapy as an approach for cell targeting</ArticleTitle>
                  <JournalTitle>Journal of Molecular Medicine (Berlin)</JournalTitle>
                  <VolumeID>74</VolumeID>
                  <FirstPage>379</FirstPage>
                  <LastPage>392</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XltVWjtro%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1007/BF00210632</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Walther W, Stein U. Cell type specific and inducible promoters for vectors in gene therapy as an approach for cell targeting.<Emphasis Type="Italic">Journal of Molecular Medicine (Berlin)</Emphasis>. 1996;74:379–392.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Qin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Ding</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DR</Initials>
                    <FamilyName>Pahud</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Chang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Imperiale</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JS</Initials>
                    <FamilyName>Bromberg</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression</ArticleTitle>
                  <JournalTitle>Hum Gene Ther</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>2019</FirstPage>
                  <LastPage>2029</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9414251</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXnslSktLk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1089/hum.1997.8.17-2019</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Qin L, Ding Y, Pahud DR, Chang E, Imperiale MJ, Bromberg JS. Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression.<Emphasis Type="Italic">Hum Gene Ther</Emphasis>. 1997;8:2019–2029.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Paillard</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Promoter attenuation in gene therapy: causes and remedies</ArticleTitle>
                  <JournalTitle>Hum Gene Ther</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>2009</FirstPage>
                  <LastPage>2010</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9414249</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXnslSktL0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Paillard F. Promoter attenuation in gene therapy: causes and remedies.<Emphasis Type="Italic">Hum Gene Ther</Emphasis>. 1997;8:2009–2010.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RD</Initials>
                    <FamilyName>Weeratna</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Wu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Etler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HL</Initials>
                    <FamilyName>Davis</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters</ArticleTitle>
                  <JournalTitle>Gene Ther</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>1872</FirstPage>
                  <LastPage>1878</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11821941</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XpsFartA%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.gt.3301602</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Weeratna RD, Wu T, Etler SM, Zhang L, Davis HL. Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters.<Emphasis Type="Italic">Gene Ther</Emphasis>. 2001;8:1872–1878.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Greco</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Marples</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GU</Initials>
                    <FamilyName>Dachs</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KJ</Initials>
                    <FamilyName>Williams</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AV</Initials>
                    <FamilyName>Patterson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SD</Initials>
                    <FamilyName>Scott</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Novel chimeric gene promoters responsive to hypoxia and ionizing radiation</ArticleTitle>
                  <JournalTitle>Gene Ther</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <FirstPage>1403</FirstPage>
                  <LastPage>1411</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12365006</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XnsFaitr0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.gt.3301823</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Greco O, Marples B, Dachs GU, Williams KJ, Patterson AV, Scott SD. Novel chimeric gene promoters responsive to hypoxia and ionizing radiation.<Emphasis Type="Italic">Gene Ther</Emphasis> 2002;9:1403–1411.</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>WF</Initials>
                    <FamilyName>Anderson</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Human gene therapy</ArticleTitle>
                  <JournalTitle>Nature (London)</JournalTitle>
                  <VolumeID>392</VolumeID>
                  <IssueID>suppl 6679</IssueID>
                  <FirstPage>25</FirstPage>
                  <LastPage>30</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXjtVyltb0%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1126/science.1589762</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Anderson WF. Human gene therapy.<Emphasis Type="Italic">Nature (London)</Emphasis>. 1998;392(suppl 6679):25–30.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Vorburger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KK</Initials>
                    <FamilyName>Hunt</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Adenovirall gene therapy</ArticleTitle>
                  <JournalTitle>Oncologist</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>46</FirstPage>
                  <LastPage>59</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11854546</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XitVChtL4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1634/theoncologist.7-1-46</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Vorburger SA, Hunt KK. Adenovirall gene therapy.<Emphasis Type="Italic">Oncologist</Emphasis>. 2002;7:46–59.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>22.</CitationNumber>
                <BibUnstructured>China OKs Gene Therapy Drug.<Emphasis Type="Italic">Genetic Engineering News</Emphasis>. 2003: 6.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Galanis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Russell</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Cancer gene therapy clinical trials: lessons for the future</ArticleTitle>
                  <JournalTitle>Br J Cancer</JournalTitle>
                  <VolumeID>85</VolumeID>
                  <FirstPage>1432</FirstPage>
                  <LastPage>1436</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11720424</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XkslensQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1054/bjoc.2001.2129</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Galanis E, Russell S. Cancer gene therapy clinical trials: lessons for the future.<Emphasis Type="Italic">Br J Cancer</Emphasis> 2001;85:1432–1436.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Mulherkar</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Gene therapy for cancer</ArticleTitle>
                  <JournalTitle>Curr Sci.</JournalTitle>
                  <VolumeID>81</VolumeID>
                  <FirstPage>555</FirstPage>
                  <LastPage>560</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXns1ymu7Y%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mulherkar R. Gene therapy for cancer.<Emphasis Type="Italic">Curr Sci.</Emphasis> 2001;81:555–560.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Baekelandt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Strooper</FamilyName>
                    <Particle>De</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Nuttin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Z</Initials>
                    <FamilyName>Debyser</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Gene therapeutic strategies for neurodegenerative diseases</ArticleTitle>
                  <JournalTitle>Curr Opin Mol Ther</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <FirstPage>540</FirstPage>
                  <LastPage>554</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11249757</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXnvVOjtrY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Baekelandt V, De Strooper B, Nuttin B, Debyser Z. Gene therapeutic strategies for neurodegenerative diseases.<Emphasis Type="Italic">Curr Opin Mol Ther</Emphasis>. 2000;2:540–554.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BA</Initials>
                    <FamilyName>Bunnell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RA</Initials>
                    <FamilyName>Morgan</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Gene therapy for HIV infection</ArticleTitle>
                  <JournalTitle>Drugs Today</JournalTitle>
                  <VolumeID>32</VolumeID>
                  <FirstPage>209</FirstPage>
                  <LastPage>224</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XjsFWhu74%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bunnell BA, Morgan RA. Gene therapy for HIV infection.<Emphasis Type="Italic">Drugs Today</Emphasis> 1996;32:209–224.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AA</Initials>
                    <FamilyName>Horner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Uden</FamilyName>
                    <Particle>Van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Zubeldia</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Broide</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Raz</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">DNA-based immunotherapeutics for the treatment of allergic disease</ArticleTitle>
                  <JournalTitle>Immunol Rev.</JournalTitle>
                  <VolumeID>179</VolumeID>
                  <FirstPage>102</FirstPage>
                  <LastPage>118</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11292014</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXhvFektr8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1034/j.1600-065X.2001.790111.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Horner AA, Van Uden JH, Zubeldia JM, Broide D, Raz E. DNA-based immunotherapeutics for the treatment of allergic disease.<Emphasis Type="Italic">Immunol Rev.</Emphasis> 2001;179:102–118.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ST</Initials>
                    <FamilyName>Crooke</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Molecular mechanisms of action of antisense drugs</ArticleTitle>
                  <JournalTitle>Biochim Biophys Acta</JournalTitle>
                  <VolumeID>1489</VolumeID>
                  <FirstPage>31</FirstPage>
                  <LastPage>43</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10806995</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXns1Sltb8%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/S0167-4781(99)00148-7</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Crooke ST. Molecular mechanisms of action of antisense drugs.<Emphasis Type="Italic">Biochim Biophys Acta</Emphasis>. 1999;1489:31–43.</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ST</Initials>
                    <FamilyName>Crooke</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Molecular mechanisms of antisense drugs: human RNase H</ArticleTitle>
                  <JournalTitle>Antisense Nucleic Acid Drug Dev</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <FirstPage>377</FirstPage>
                  <LastPage>379</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXlsVygs7k%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Crooke ST. Molecular mechanisms of antisense drugs: human RNase H.<Emphasis Type="Italic">Antisense Nucleic Acid Drug Dev</Emphasis> 1999;9:377–379.</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>30.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Engels</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Uhlmann</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ChapterTitle Language="En">Chemistry of Oligonucleotides</ChapterTitle>
                  <BibEditorName>
                    <Initials>C</Initials>
                    <FamilyName>Malvy</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Pharmaceutical Aspects of Oligonucleotides</BookTitle>
                  <PublisherName>Taylor &amp; Francis Ltd</PublisherName>
                  <PublisherLocation>London, UK</PublisherLocation>
                  <FirstPage>35</FirstPage>
                  <LastPage>78</LastPage>
                </BibChapter>
                <BibUnstructured>Engels JW, Uhlmann E. Chemistry of Oligonucleotides. In: Malvy C, ed.<Emphasis Type="Italic">Pharmaceutical Aspects of Oligonucleotides</Emphasis>. London, UK: Taylor &amp; Francis Ltd; 2000;35–78.</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>31.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Khatsenko</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Morgan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Truong</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Absorption of antisense oligonucleotides in rat intestine: effect of chemistry and length</ArticleTitle>
                  <JournalTitle>Antisense Nucleic Acid Drug Dev</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>35</FirstPage>
                  <LastPage>44</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10726659</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXhs1ajs7Y%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1089/oli.1.2000.10.35</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Khatsenko O, Morgan R, Truong L, et al. Absorption of antisense oligonucleotides in rat intestine: effect of chemistry and length.<Emphasis Type="Italic">Antisense Nucleic Acid Drug Dev</Emphasis> 2000;10:35–44.</BibUnstructured>
              </Citation>
              <Citation ID="CR31">
                <CitationNumber>32.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CA</Initials>
                    <FamilyName>Stein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Subasinghe</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Shinozuka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JS</Initials>
                    <FamilyName>Cohen</FamilyName>
                  </BibAuthorName>
                  <Year>1988</Year>
                  <ArticleTitle Language="En">Physicochemical properties of phosphorothioate oligodeoxynucleotides</ArticleTitle>
                  <JournalTitle>Nucleic Acids Res</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <FirstPage>3209</FirstPage>
                  <LastPage>3221</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2836790</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1cXlsVCktLc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/nar/16.8.3209</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Stein CA, Subasinghe C, Shinozuka K, Cohen JS. Physicochemical properties of phosphorothioate oligodeoxynucleotides.<Emphasis Type="Italic">Nucleic Acids Res</Emphasis>. 1988;16:3209–3221.</BibUnstructured>
              </Citation>
              <Citation ID="CR32">
                <CitationNumber>33.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Matteucci</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Structural modifications toward improved antisense oligonucleotides</ArticleTitle>
                  <JournalTitle>Perspectives in Drug Discovery and Design</JournalTitle>
                  <VolumeID>4</VolumeID>
                  <FirstPage>1</FirstPage>
                  <LastPage>16</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XhslCqsr0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/BF02172105</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Matteucci M. Structural modifications toward improved antisense oligonucleotides.<Emphasis Type="Italic">Perspectives in Drug Discovery and Design</Emphasis>. 1996;4(Antisense Therapeutics):1–16.</BibUnstructured>
              </Citation>
              <Citation ID="CR33">
                <CitationNumber>34.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Shoji</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Akhtar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Periasamy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Herman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RL</Initials>
                    <FamilyName>Juliano</FamilyName>
                  </BibAuthorName>
                  <Year>1991</Year>
                  <ArticleTitle Language="En">Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages</ArticleTitle>
                  <JournalTitle>Nucleic Acids Res.</JournalTitle>
                  <VolumeID>19</VolumeID>
                  <FirstPage>5543</FirstPage>
                  <LastPage>5550</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1658734</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3MXmslKksr4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/nar/19.20.5543</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Shoji Y, Akhtar S, Periasamy A, Herman B, Juliano RL. Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages.<Emphasis Type="Italic">Nucleic Acids Res.</Emphasis> 1991;19:5543–5550.</BibUnstructured>
              </Citation>
              <Citation ID="CR34">
                <CitationNumber>35.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Akhtar</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Antisense technology: selection and delivery of optimally acting antisense oligonucleotides</ArticleTitle>
                  <JournalTitle>J Drug Target</JournalTitle>
                  <VolumeID>5</VolumeID>
                  <FirstPage>225</FirstPage>
                  <LastPage>234</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9713973</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXltlWnsrw%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.3109/10611869808995877</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Akhtar S. Antisense technology: selection and delivery of optimally acting antisense oligonucleotides.<Emphasis Type="Italic">J Drug Target</Emphasis>. 1998;5:225–234.</BibUnstructured>
              </Citation>
              <Citation ID="CR35">
                <CitationNumber>36.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Smith</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KB</Initials>
                    <FamilyName>Andersen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Hovgaard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Jaroszewski</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Rational selection of antisense oligonucleotide sequences</ArticleTitle>
                  <JournalTitle>Eur J Pharm Sci</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>191</FirstPage>
                  <LastPage>198</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11042224</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXls1Git78%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0928-0987(00)00100-7</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Smith L, Andersen KB, Hovgaard L, Jaroszewski JW. Rational selection of antisense oligonucleotide sequences.<Emphasis Type="Italic">Eur J Pharm Sci</Emphasis>. 2000;11:191–198.</BibUnstructured>
              </Citation>
              <Citation ID="CR36">
                <CitationNumber>37.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SD</Initials>
                    <FamilyName>Patil</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DG</Initials>
                    <FamilyName>Rhodes</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Influence of divalent cations on the conformation of phosphorothioate oligodeoxynucleotides: a circular dichroism study</ArticleTitle>
                  <JournalTitle>Nucleic Acids Res</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>2439</FirstPage>
                  <LastPage>2445</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10871378</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXkslait7Y%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/nar/28.12.2439</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Patil SD, Rhodes DG. Influence of divalent cations on the conformation of phosphorothioate oligodeoxynucleotides: a circular dichroism study.<Emphasis Type="Italic">Nucleic Acids Res</Emphasis>. 2000;28:2439–2445.</BibUnstructured>
              </Citation>
              <Citation ID="CR37">
                <CitationNumber>38.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Agrawal</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Tan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Q</Initials>
                    <FamilyName>Cai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>X</Initials>
                    <FamilyName>Xie</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">In vivo pharmacokinetics of phosphorothioate oligonucleotides containing contiguous guanosines</ArticleTitle>
                  <JournalTitle>Antisense Nucleic Acid Drug Dev</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>245</FirstPage>
                  <LastPage>249</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9212919</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXktFWksLc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Agrawal S, Tan W, Cai Q, Xie X, Zhang R. In vivo pharmacokinetics of phosphorothioate oligonucleotides containing contiguous guanosines.<Emphasis Type="Italic">Antisense Nucleic Acid Drug Dev</Emphasis> 1997;7:245–249.</BibUnstructured>
              </Citation>
              <Citation ID="CR38">
                <CitationNumber>39.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Akhtar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MD</Initials>
                    <FamilyName>Hughes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Khan</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">The delivery of antisense therapeutics</ArticleTitle>
                  <JournalTitle>Adv Drug Deliv Rev</JournalTitle>
                  <VolumeID>44</VolumeID>
                  <FirstPage>3</FirstPage>
                  <LastPage>21</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11035194</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXotlCitrs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0169-409X(00)00080-6</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Akhtar S, Hughes MD, Khan A, et al. The delivery of antisense therapeutics.<Emphasis Type="Italic">Adv Drug Deliv Rev</Emphasis>. 2000;44:3–21.</BibUnstructured>
              </Citation>
              <Citation ID="CR39">
                <CitationNumber>40.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ST</Initials>
                    <FamilyName>Crooke</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Vitravene another piece in the mosaic</ArticleTitle>
                  <JournalTitle>Antisense Nucleic Acid Drug Dev</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>vii</FirstPage>
                  <LastPage>v3</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9743463</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXlvFGgt7s%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Crooke ST. Vitravene another piece in the mosaic.<Emphasis Type="Italic">Antisense Nucleic Acid Drug Dev</Emphasis>. 1998;8:vii-v3.</BibUnstructured>
              </Citation>
              <Citation ID="CR40">
                <CitationNumber>41.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Merdan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Kopecek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Kissel</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Prospects for cationic polymers in gene and oligonucleotide therapy against cancer</ArticleTitle>
                  <JournalTitle>Adv Drug Deliv Rev.</JournalTitle>
                  <VolumeID>54</VolumeID>
                  <FirstPage>715</FirstPage>
                  <LastPage>758</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12204600</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XmsVeqtrc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0169-409X(02)00046-7</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Merdan T, Kopecek J, Kissel T. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer.<Emphasis Type="Italic">Adv Drug Deliv Rev.</Emphasis> 2002;54:715–758.</BibUnstructured>
              </Citation>
              <Citation ID="CR41">
                <CitationNumber>42.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Aigner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Juhl</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Malerczyk</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Tkybusch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CC</Initials>
                    <FamilyName>Benz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Czubayko</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumor cell proliferation</ArticleTitle>
                  <JournalTitle>Oncogene</JournalTitle>
                  <VolumeID>20</VolumeID>
                  <FirstPage>2101</FirstPage>
                  <LastPage>2111</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11360194</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXjsVCht7k%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.onc.1204305</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Aigner A, Juhl H, Malerczyk C, Tkybusch A, Benz CC, Czubayko F. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumor cell proliferation.<Emphasis Type="Italic">Oncogene</Emphasis>. 2001;20:2101–2111.</BibUnstructured>
              </Citation>
              <Citation ID="CR42">
                <CitationNumber>43.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WJ</Initials>
                    <FamilyName>Gasper</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Stass</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>OB</Initials>
                    <FamilyName>Ioffe</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Davis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AJ</Initials>
                    <FamilyName>Mixson</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Angiogenic inhibition mediated by a DNA zyme that targets vascular endothelial growth factor receptor 2</ArticleTitle>
                  <JournalTitle>Cancer Res</JournalTitle>
                  <VolumeID>62</VolumeID>
                  <FirstPage>5463</FirstPage>
                  <LastPage>5469</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12359754</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xnsl2ls7Y%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zhang L, Gasper WJ, Stass SA, Ioffe OB, Davis MA, Mixson AJ. Angiogenic inhibition mediated by a DNA zyme that targets vascular endothelial growth factor receptor 2.<Emphasis Type="Italic">Cancer Res</Emphasis> 2002;62:5463–5469.</BibUnstructured>
              </Citation>
              <Citation ID="CR43">
                <CitationNumber>44.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SD</Initials>
                    <FamilyName>Jayasena</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Aptamers: an emerging class of molecules that rival antibodies in diagnostics</ArticleTitle>
                  <JournalTitle>Clin Chem.</JournalTitle>
                  <VolumeID>45</VolumeID>
                  <IssueID>9</IssueID>
                  <FirstPage>1628</FirstPage>
                  <LastPage>1650</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10471678</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXlvFertrk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jayasena SD. Aptamers: an emerging class of molecules that rival antibodies in diagnostics.<Emphasis Type="Italic">Clin Chem.</Emphasis> 1999;45(9):1628–1650.</BibUnstructured>
              </Citation>
              <Citation ID="CR44">
                <CitationNumber>45.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>VR</Initials>
                    <FamilyName>Soultrait</FamilyName>
                    <Particle>de</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P-Y</Initials>
                    <FamilyName>Lozach</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Altmeyer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Tarrago-Litvak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Litvak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ML</Initials>
                    <FamilyName>Andreola</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">DNA aptamers derived from HIV-I RNase H inhibitors are strong anti-integrase agents</ArticleTitle>
                  <JournalTitle>J Mol Biol</JournalTitle>
                  <VolumeID>324</VolumeID>
                  <FirstPage>195</FirstPage>
                  <LastPage>203</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12441099</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0022-2836(02)01064-1</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xos1GntrY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>de Soultrait VR, Lozach P-Y, Altmeyer R, Tarrago-Litvak L, Litvak S, Andreola ML. DNA aptamers derived from HIV-I RNase H inhibitors are strong anti-integrase agents.<Emphasis Type="Italic">J Mol Biol</Emphasis>. 2002;324:195–203.</BibUnstructured>
              </Citation>
              <Citation ID="CR45">
                <CitationNumber>46.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Chaloin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Lehmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Sczakiel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Restle</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1</ArticleTitle>
                  <JournalTitle>Nucleic Acids Res</JournalTitle>
                  <VolumeID>30</VolumeID>
                  <FirstPage>4001</FirstPage>
                  <LastPage>4008</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12235384</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xnt1Gmsr4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/nar/gkf522</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Chaloin L, Lehmann MJ, Sczakiel G, Restle T. Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1.<Emphasis Type="Italic">Nucleic Acids Res</Emphasis>. 2002;30:4001–4008.</BibUnstructured>
              </Citation>
              <Citation ID="CR46">
                <CitationNumber>47.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J-R</Initials>
                    <FamilyName>Bertrand</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Pottier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Vekris</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Opolon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Maksimenko</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Malvy</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo</ArticleTitle>
                  <JournalTitle>Biochem Biophys Res Commun</JournalTitle>
                  <VolumeID>296</VolumeID>
                  <FirstPage>1000</FirstPage>
                  <LastPage>1004</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12200148</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XmsV2ku7Y%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0006-291X(02)02013-2</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bertrand J-R, Pottier M, Vekris A, Opolon P, Maksimenko A, Malvy C. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo.<Emphasis Type="Italic">Biochem Biophys Res Commun</Emphasis>. 2002;296:1000–1004.</BibUnstructured>
              </Citation>
              <Citation ID="CR47">
                <CitationNumber>48.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MT</Initials>
                    <FamilyName>McManus</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Sharp</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Gene silencing in mammals by small interfering RNAs</ArticleTitle>
                  <JournalTitle>Nat Rev Genet</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>737</FirstPage>
                  <LastPage>747</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12360232</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XnsVGqs7k%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/nrg908</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>McManus MT, Sharp PA. Gene silencing in mammals by small interfering RNAs.<Emphasis Type="Italic">Nat Rev Genet</Emphasis>. 2002;3:737–747.</BibUnstructured>
              </Citation>
              <Citation ID="CR48">
                <CitationNumber>49.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Scherr</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Morgan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Eder</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Gene silencing mediated by small interfering RNAs in mammalian cells</ArticleTitle>
                  <JournalTitle>Curr Med Chem</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>245</FirstPage>
                  <LastPage>256</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12570711</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXlt1Ghuw%3D%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.2174/0929867033368493</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Scherr M, Morgan MA, Eder M. Gene silencing mediated by small interfering RNAs in mammalian cells.<Emphasis Type="Italic">Curr Med Chem</Emphasis>. 2003;10:245–256.</BibUnstructured>
              </Citation>
              <Citation ID="CR49">
                <CitationNumber>50.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Kurreck</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Antisense technologies: improvement through movel chemical modifications</ArticleTitle>
                  <JournalTitle>Eur J Biochem</JournalTitle>
                  <VolumeID>270</VolumeID>
                  <FirstPage>1628</FirstPage>
                  <LastPage>1644</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12694176</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXjtl2jtbc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1432-1033.2003.03555.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kurreck J. Antisense technologies: improvement through movel chemical modifications.<Emphasis Type="Italic">Eur J Biochem</Emphasis>. 2003;270:1628–1644.</BibUnstructured>
              </Citation>
              <Citation ID="CR50">
                <CitationNumber>51.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Martinez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Gutierrez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Armand-Ugon</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication</ArticleTitle>
                  <JournalTitle>AIDS</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <IssueID>18</IssueID>
                  <FirstPage>2385</FirstPage>
                  <LastPage>2390</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12461411</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XptFKgurY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00002030-200212060-00002</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Martinez MA, Gutierrez A, Armand-Ugon M, et al. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication.<Emphasis Type="Italic">AIDS</Emphasis>. 2002;16(18):2385–2390.</BibUnstructured>
              </Citation>
              <Citation ID="CR51">
                <CitationNumber>52.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PD</Initials>
                    <FamilyName>Zamore</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Aronin</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">siRNAs knock down hepatitis</ArticleTitle>
                  <JournalTitle>Nat Med</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <IssueID>3</IssueID>
                  <FirstPage>266</FirstPage>
                  <LastPage>267</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12612573</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXhsFGgsrY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/nm0303-266</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zamore PD, Aronin N. siRNAs knock down hepatitis.<Emphasis Type="Italic">Nat Med</Emphasis>. 2003;9(3):266–267.</BibUnstructured>
              </Citation>
              <Citation ID="CR52">
                <CitationNumber>53.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Q</Initials>
                    <FamilyName>Ge</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MT</Initials>
                    <FamilyName>McManus</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Nguyen</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>100</VolumeID>
                  <FirstPage>2718</FirstPage>
                  <LastPage>2723</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12594334</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXitVait74%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.0437841100</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ge Q, McManus MT, Nguyen T, et al. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2003;100:2718–2723.</BibUnstructured>
              </Citation>
              <Citation ID="CR53">
                <CitationNumber>54.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RM</Initials>
                    <FamilyName>Bennett</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">As nature intended? The uptake of DNA and oligonucleotides by eukaryotic cells</ArticleTitle>
                  <JournalTitle>Antisense Res Dev</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>235</FirstPage>
                  <LastPage>241</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8286924</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2c7hsFWmtg%3D%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1089/ard.1993.3.235</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Bennett RM. As nature intended? The uptake of DNA and oligonucleotides by eukaryotic cells.<Emphasis Type="Italic">Antisense Res Dev</Emphasis>. 1993;3:235–241.</BibUnstructured>
              </Citation>
              <Citation ID="CR54">
                <CitationNumber>56.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Doan</FamilyName>
                    <Particle>Le</Particle>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Cell binding and internalisation of oligonucleotides</ArticleTitle>
                  <JournalTitle>S.T.P. Pharma Sciences</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>75</FirstPage>
                  <LastPage>82</LastPage>
                </BibArticle>
                <BibUnstructured>Le Doan T. Cell binding and internalisation of oligonucleotides.<Emphasis Type="Italic">S.T.P. Pharma Sciences</Emphasis>. 2001;11:75–82.</BibUnstructured>
              </Citation>
              <Citation ID="CR55">
                <CitationNumber>57.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ST</Initials>
                    <FamilyName>Crooke</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Delivery of oligonucleotides and polynucleotides</ArticleTitle>
                  <JournalTitle>J Drug Target</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>185</FirstPage>
                  <LastPage>190</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8705251</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXpvVSrtrY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.3109/10611869509015944</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Crooke ST. Delivery of oligonucleotides and polynucleotides.<Emphasis Type="Italic">J Drug Target</Emphasis>. 1995;3:185–190.</BibUnstructured>
              </Citation>
              <Citation ID="CR56">
                <CitationNumber>58.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MD</Initials>
                    <FamilyName>Hughes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Hussain</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Q</Initials>
                    <FamilyName>Nawaz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Sayyed</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Akhtar</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">The cellular delivery of antisense oligonucleotides and ribozymes</ArticleTitle>
                  <JournalTitle>Drug Discov Today</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>303</FirstPage>
                  <LastPage>315</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11257582</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXhvVWrsLg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S1359-6446(00)00326-3</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hughes MD, Hussain M, Nawaz Q, Sayyed P, Akhtar S. The cellular delivery of antisense oligonucleotides and ribozymes.<Emphasis Type="Italic">Drug Discov Today</Emphasis>. 2001;6:303–315.</BibUnstructured>
              </Citation>
              <Citation ID="CR57">
                <CitationNumber>59.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Liu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Huang</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Development of non-viral vectors for systemic gene delivery</ArticleTitle>
                  <JournalTitle>J Control Release</JournalTitle>
                  <VolumeID>78</VolumeID>
                  <IssueID>1–3</IssueID>
                  <FirstPage>259</FirstPage>
                  <LastPage>266</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11772466</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXptlait7w%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0168-3659(01)00494-1</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Liu F, Huang L. Development of non-viral vectors for systemic gene delivery.<Emphasis Type="Italic">J Control Release</Emphasis>. 2002;78(1–3):259–266.</BibUnstructured>
              </Citation>
              <Citation ID="CR58">
                <CitationNumber>60.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Akhtar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RL</Initials>
                    <FamilyName>Juliano</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Cellular uptake and intracellular fate of antisense oligonucleotides</ArticleTitle>
                  <JournalTitle>Trends Cell Biol</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <FirstPage>139</FirstPage>
                  <LastPage>144</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14731968</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXjsVCrtg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0962-8924(92)90100-2</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Akhtar S, Juliano RL. Cellular uptake and intracellular fate of antisense oligonucleotides.<Emphasis Type="Italic">Trends Cell Biol</Emphasis>. 1992;2:139–144.</BibUnstructured>
              </Citation>
              <Citation ID="CR59">
                <CitationNumber>61.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Wu-Pong</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Alternative interpretations of the oligonucleotide transport literature: insights from nature</ArticleTitle>
                  <JournalTitle>Adv Drug Deliv Rev</JournalTitle>
                  <VolumeID>44</VolumeID>
                  <FirstPage>59</FirstPage>
                  <LastPage>70</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11035198</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXotlCitrc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0169-409X(00)00084-3</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wu-Pong S. Alternative interpretations of the oligonucleotide transport literature: insights from nature.<Emphasis Type="Italic">Adv Drug Deliv Rev</Emphasis>. 2000;44:59–70.</BibUnstructured>
              </Citation>
              <Citation ID="CR60">
                <CitationNumber>62.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AR</Initials>
                    <FamilyName>Holmes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AF</Initials>
                    <FamilyName>Dohrman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AR</Initials>
                    <FamilyName>Ellison</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KK</Initials>
                    <FamilyName>Gonez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DC</Initials>
                    <FamilyName>Gruenert</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Intracellular compartmentalization of DNA fragments in cultured airway epithelial cells mediated by cationic lipids</ArticleTitle>
                  <JournalTitle>Pharm Res</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <FirstPage>1020</FirstPage>
                  <LastPage>1025</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10450925</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXltVyhsrg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1018927531003</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Holmes AR, Dohrman AF, Ellison AR, Gonez KK, Gruenert DC. Intracellular compartmentalization of DNA fragments in cultured airway epithelial cells mediated by cationic lipids.<Emphasis Type="Italic">Pharm Res</Emphasis>. 1999;16:1020–1025.</BibUnstructured>
              </Citation>
              <Citation ID="CR61">
                <CitationNumber>63.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Kamiya</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Tsuchiya</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Yamazaki</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Harashima</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Intracellular trafficking and transgene expression of viral and non-viral gene vectors</ArticleTitle>
                  <JournalTitle>Adv Drug Deliv Rev</JournalTitle>
                  <VolumeID>52</VolumeID>
                  <FirstPage>153</FirstPage>
                  <LastPage>164</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11718940</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXosFKltL0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0169-409X(01)00216-2</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kamiya H, Tsuchiya H, Yamazaki J, Harashima H. Intracellular trafficking and transgene expression of viral and non-viral gene vectors.<Emphasis Type="Italic">Adv Drug Deliv Rev</Emphasis>. 2001;52:153–164.</BibUnstructured>
              </Citation>
              <Citation ID="CR62">
                <CitationNumber>64.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Tachibana</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Harashima</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Shinohara</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Kiwada</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Quantitative studies on the nuclear transport of plasmid DNA and gene expression employing nonviral vectors</ArticleTitle>
                  <JournalTitle>Adv Drug Deliv Rev</JournalTitle>
                  <VolumeID>52</VolumeID>
                  <FirstPage>219</FirstPage>
                  <LastPage>226</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11718946</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXosFKltLc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0169-409X(01)00211-3</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Tachibana R, Harashima H, Shinohara Y, Kiwada H. Quantitative studies on the nuclear transport of plasmid DNA and gene expression employing nonviral vectors.<Emphasis Type="Italic">Adv Drug Deliv Rev</Emphasis>. 2001;52:219–226.</BibUnstructured>
              </Citation>
              <Citation ID="CR63">
                <CitationNumber>65.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MD</Initials>
                    <FamilyName>Brown</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AG</Initials>
                    <FamilyName>Schatzlein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>IF</Initials>
                    <FamilyName>Uchegbu</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Gene delivery with synthetic (non viral) carriers</ArticleTitle>
                  <JournalTitle>Int J Pharm</JournalTitle>
                  <VolumeID>229</VolumeID>
                  <IssueID>1–2</IssueID>
                  <FirstPage>1</FirstPage>
                  <LastPage>21</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11604253</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXntlKnsLk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0378-5173(01)00861-4</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Brown MD, Schatzlein AG, Uchegbu IF. Gene delivery with synthetic (non viral) carriers.<Emphasis Type="Italic">Int J Pharm</Emphasis>. 2001;229(1–2):1–21.</BibUnstructured>
              </Citation>
              <Citation ID="CR64">
                <CitationNumber>66.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Luo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WM</Initials>
                    <FamilyName>Saltzman</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Synthetic DNA delivery systems</ArticleTitle>
                  <JournalTitle>Nat Biotechnol.</JournalTitle>
                  <VolumeID>18</VolumeID>
                  <FirstPage>33</FirstPage>
                  <LastPage>37</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10625387</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXjs12jsQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/71889</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Luo D, Saltzman WM. Synthetic DNA delivery systems.<Emphasis Type="Italic">Nat Biotechnol.</Emphasis>. 2000;18:33–37.</BibUnstructured>
              </Citation>
              <Citation ID="CR65">
                <CitationNumber>67.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Agrawal</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Pharmacokinetics of oligonucleotides</ArticleTitle>
                  <JournalTitle>Ciba Foundation Symposium</JournalTitle>
                  <VolumeID>209</VolumeID>
                  <FirstPage>60</FirstPage>
                  <LastPage>78</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9383569</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXmvFaltbg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Agrawal S, Zhang R. Pharmacokinetics of oligonucleotides.<Emphasis Type="Italic">Ciba Foundation Symposium</Emphasis>. 1997;209(Oligonucleotides as Therapeutic Agents):60–78.</BibUnstructured>
              </Citation>
              <Citation ID="CR66">
                <CitationNumber>68.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RZ</Initials>
                    <FamilyName>Yu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RS</Initials>
                    <FamilyName>Geary</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Leeds</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Pharmacokinetics and tissue disposition in monkeys of an antisense oligonucleotide inhibitor of ha-ras encapsulated in stealth liposomes</ArticleTitle>
                  <JournalTitle>Pharm Res</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <FirstPage>1309</FirstPage>
                  <LastPage>1315</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10468036</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXlsVyntbs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1014822219133</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yu RZ, Geary RS, Leeds JM, et al. Pharmacokinetics and tissue disposition in monkeys of an antisense oligonucleotide inhibitor of ha-ras encapsulated in stealth liposomes.<Emphasis Type="Italic">Pharm Res</Emphasis>. 1999;16:1309–1315.</BibUnstructured>
              </Citation>
              <Citation ID="CR67">
                <CitationNumber>69.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Tam</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Monck</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Stabilized plasmid-lipid particles for systemic gene therapy</ArticleTitle>
                  <JournalTitle>Gene Ther</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>1867</FirstPage>
                  <LastPage>1874</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11110420</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXotFaiur8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.gt.3301308</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Tam P, Monck M, Lee D, et al. Stabilized plasmid-lipid particles for systemic gene therapy.<Emphasis Type="Italic">Gene Ther</Emphasis>. 2000;7:1867–1874.</BibUnstructured>
              </Citation>
              <Citation ID="CR68">
                <CitationNumber>70.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Kunisawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Nakagawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Mayumi</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development</ArticleTitle>
                  <JournalTitle>Adv Drug Deliv Rev</JournalTitle>
                  <VolumeID>52</VolumeID>
                  <FirstPage>177</FirstPage>
                  <LastPage>186</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11718942</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXosFKltLs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0169-409X(01)00214-9</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kunisawa J, Nakagawa S, Mayumi T. Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development.<Emphasis Type="Italic">Adv Drug Deliv Rev</Emphasis>. 2001;52:177–186.</BibUnstructured>
              </Citation>
              <Citation ID="CR69">
                <CitationNumber>71.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Hope</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Mui</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ansell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>QF</Initials>
                    <FamilyName>Ahkong</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs</ArticleTitle>
                  <JournalTitle>Mol Membr Biol.</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>1</FirstPage>
                  <LastPage>14</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9595549</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXis1Wmsb0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.3109/09687689809027512</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hope MJ, Mui B, Ansell S, Ahkong QF. Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs.<Emphasis Type="Italic">Mol Membr Biol.</Emphasis>. 1998;15:1–14.</BibUnstructured>
              </Citation>
              <Citation ID="CR70">
                <CitationNumber>72.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Jaaskelainen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Moenkkoenen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Urtti</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Oligonucleotide-cationic liposome interactions. A physicochemical study</ArticleTitle>
                  <JournalTitle>Biochim Biophys Acta</JournalTitle>
                  <VolumeID>1195</VolumeID>
                  <FirstPage>115</FirstPage>
                  <LastPage>123</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7918553</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2M%2Fgt1Sltg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0005-2736(94)90017-5</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jaaskelainen I, Moenkkoenen J, Urtti A. Oligonucleotide-cationic liposome interactions. A physicochemical study.<Emphasis Type="Italic">Biochim Biophys Acta</Emphasis>. 1994;1195:115–123.</BibUnstructured>
              </Citation>
              <Citation ID="CR71">
                <CitationNumber>73.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Jaaskelainen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Sternberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Monkkonen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Urtti</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Physicochemical and morphological properties of complexes made of cationic liposomes and oligonucleotides</ArticleTitle>
                  <JournalTitle>Int J Pharm</JournalTitle>
                  <VolumeID>167</VolumeID>
                  <IssueID>1–2</IssueID>
                  <FirstPage>191</FirstPage>
                  <LastPage>203</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXksF2mu7c%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0378-5173(98)00067-2</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jaaskelainen I, Sternberg B, Monkkonen J, Urtti A. Physicochemical and morphological properties of complexes made of cationic liposomes and oligonucleotides.<Emphasis Type="Italic">Int J Pharm</Emphasis>. 1998; 167(1–2):191–203.</BibUnstructured>
              </Citation>
              <Citation ID="CR72">
                <CitationNumber>74.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P-A</Initials>
                    <FamilyName>Monnard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Oberholzer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Luisi</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Entrapment of nucleic acids in liposomes</ArticleTitle>
                  <JournalTitle>Biochim Biophys Acta</JournalTitle>
                  <VolumeID>1329</VolumeID>
                  <FirstPage>39</FirstPage>
                  <LastPage>50</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9370243</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXlslenu7c%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0005-2736(97)00066-7</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Monnard P-A, Oberholzer T, Luisi P. Entrapment of nucleic acids in liposomes.<Emphasis Type="Italic">Biochim Biophys Acta</Emphasis>. 1997;1329:39–50.</BibUnstructured>
              </Citation>
              <Citation ID="CR73">
                <CitationNumber>75.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DV</Initials>
                    <FamilyName>McAllister</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MG</Initials>
                    <FamilyName>Allen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MR</Initials>
                    <FamilyName>Prausnitz</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Microfabricated microneedles for gene and drug delivery</ArticleTitle>
                  <JournalTitle>Annu Rev Biomed Eng</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <FirstPage>289</FirstPage>
                  <LastPage>313</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11701514</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXnsVaktbw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1146/annurev.bioeng.2.1.289</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles for gene and drug delivery.<Emphasis Type="Italic">Annu Rev Biomed Eng</Emphasis>. 2000;2:289–313.</BibUnstructured>
              </Citation>
              <Citation ID="CR74">
                <CitationNumber>76.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Regnier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Tahiri</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Andre</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Lemaitre</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Le</FamilyName>
                    <Particle>Doan</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Preat</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Electroporation-mediated delivery of 3′-protected phosphodiester oligodeoxynucleotides to the skin</ArticleTitle>
                  <JournalTitle>J Control Release</JournalTitle>
                  <VolumeID>67</VolumeID>
                  <IssueID>2–3</IssueID>
                  <FirstPage>337</FirstPage>
                  <LastPage>346</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10825565</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXjsVegt74%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0168-3659(00)00223-6</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Regnier V, Tahiri A, Andre N, Lemaitre M, Le Doan T, Preat V. Electroporation-mediated delivery of 3′-protected phosphodiester oligodeoxynucleotides to the skin.<Emphasis Type="Italic">J Control Release</Emphasis>. 2000;67(2–3):337–346.</BibUnstructured>
              </Citation>
              <Citation ID="CR75">
                <CitationNumber>77.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Huang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Viroonchatapan</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ChapterTitle Language="En">Introduction</ChapterTitle>
                  <BibEditorName>
                    <Initials>L</Initials>
                    <FamilyName>Huang</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>M-C</Initials>
                    <FamilyName>Hung</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>E</Initials>
                    <FamilyName>Wagner</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Nonviral Vectors for Gene Therapy</BookTitle>
                  <PublisherName>Academic Press</PublisherName>
                  <PublisherLocation>San Diego, CA</PublisherLocation>
                  <FirstPage>3</FirstPage>
                  <LastPage>22</LastPage>
                </BibChapter>
                <BibUnstructured>Huang L, Viroonchatapan E. Introduction. In: Huang L, Hung M-C, Wagner E, ed.<Emphasis Type="Italic">Nonviral Vectors for Gene Therapy</Emphasis>. San Diego, CA: Academic Press; 1999:3–22.</BibUnstructured>
              </Citation>
              <Citation ID="CR76">
                <CitationNumber>78.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Mah</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BJ</Initials>
                    <FamilyName>Byrne</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TR</Initials>
                    <FamilyName>Flotte</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Virus-based gene delivery systems</ArticleTitle>
                  <JournalTitle>Clin Pharmacokinet</JournalTitle>
                  <VolumeID>41</VolumeID>
                  <FirstPage>901</FirstPage>
                  <LastPage>911</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12222993</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XotlGisbs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.2165/00003088-200241120-00001</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mah C, Byrne BJ, Flotte TR. Virus-based gene delivery systems.<Emphasis Type="Italic">Clin Pharmacokinet</Emphasis>. 2002;41:901–911.</BibUnstructured>
              </Citation>
              <Citation ID="CR77">
                <CitationNumber>79.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MT</Initials>
                    <FamilyName>Lotze</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TA</Initials>
                    <FamilyName>Kost</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Viruses as gene delivery vectors: application to gene function, target validation, and assay development</ArticleTitle>
                  <JournalTitle>Cancer Gene Ther.</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <FirstPage>692</FirstPage>
                  <LastPage>699</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12136431</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XlsVKqt7Y%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.cgt.7700493</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lotze MT, Kost TA. Viruses as gene delivery vectors: application to gene function, target validation, and assay development.<Emphasis Type="Italic">Cancer Gene Ther.</Emphasis> 2002;9:692–699.</BibUnstructured>
              </Citation>
              <Citation ID="CR78">
                <CitationNumber>80.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>McTaggart</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Al-Rubeai</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Retroviral vectors for human gene delivery</ArticleTitle>
                  <JournalTitle>Biotechnol Adv.</JournalTitle>
                  <VolumeID>20</VolumeID>
                  <FirstPage>1</FirstPage>
                  <LastPage>31</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14538060</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xjtl2ns7Y%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0734-9750(01)00087-8</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>McTaggart S, Al-Rubeai M. Retroviral vectors for human gene delivery.<Emphasis Type="Italic">Biotechnol Adv.</Emphasis>. 2002;20:1–31.</BibUnstructured>
              </Citation>
              <Citation ID="CR79">
                <CitationNumber>81.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Galimi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>IM</Initials>
                    <FamilyName>Verma</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Opportunities for the use of lentiviral vectors in human gene therapy</ArticleTitle>
                  <JournalTitle>Curr Top Microbiol Immunol</JournalTitle>
                  <VolumeID>261</VolumeID>
                  <FirstPage>245</FirstPage>
                  <LastPage>254</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11892251</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XitV2jsrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Galimi F, Verma IM. Opportunities for the use of lentiviral vectors in human gene therapy.<Emphasis Type="Italic">Curr Top Microbiol Immunol</Emphasis>. 2002;261:245–254.</BibUnstructured>
              </Citation>
              <Citation ID="CR80">
                <CitationNumber>82.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KR</Initials>
                    <FamilyName>Martin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RL</Initials>
                    <FamilyName>Klein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HA</Initials>
                    <FamilyName>Quigley</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Gene delivery to the eye using adeno-associated viral vectors</ArticleTitle>
                  <JournalTitle>Methods</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>267</FirstPage>
                  <LastPage>275</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12413426</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xot1KmsL0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S1046-2023(02)00232-3</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Martin KR, Klein RL, Quigley HA. Gene delivery to the eye using adeno-associated viral vectors.<Emphasis Type="Italic">Methods</Emphasis>. 2002;28(2):267–275.</BibUnstructured>
              </Citation>
              <Citation ID="CR81">
                <CitationNumber>83.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y-HH</Initials>
                    <FamilyName>Lien</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L-W</Initials>
                    <FamilyName>Lai</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Gene therapy for renal disorders: what are the benefits for the elderly?</ArticleTitle>
                  <JournalTitle>Drugs Aging.</JournalTitle>
                  <VolumeID>19</VolumeID>
                  <FirstPage>553</FirstPage>
                  <LastPage>560</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12207549</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XotFOqurc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.2165/00002512-200219080-00001</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lien Y-HH, Lai L-W. Gene therapy for renal disorders: what are the benefits for the elderly?.<Emphasis Type="Italic">Drugs Aging.</Emphasis>. 2002;19:553–560.</BibUnstructured>
              </Citation>
              <Citation ID="CR82">
                <CitationNumber>84.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JS</Initials>
                    <FamilyName>Chamberlain</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Gene therapy of muscular dystrophy</ArticleTitle>
                  <JournalTitle>Hum Mol Genet</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>2355</FirstPage>
                  <LastPage>2362</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12351570</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XnvVemsr8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/hmg/11.20.2355</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Chamberlain JS. Gene therapy of muscular dystrophy.<Emphasis Type="Italic">Hum Mol Genet</Emphasis>. 2002;11:2355–2362.</BibUnstructured>
              </Citation>
              <Citation ID="CR83">
                <CitationNumber>85.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JK</Initials>
                    <FamilyName>Wolf</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AD</Initials>
                    <FamilyName>Jenkins</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Gene therapy for ovarian cancer (review)</ArticleTitle>
                  <JournalTitle>Int J Oncol</JournalTitle>
                  <VolumeID>21</VolumeID>
                  <FirstPage>461</FirstPage>
                  <LastPage>468</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12168087</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xmsl2jsb4%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.3892/ijo.21.3.461</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Wolf JK, Jenkins AD. Gene therapy for ovarian cancer (review).<Emphasis Type="Italic">Int J Oncol</Emphasis>. 2002;21:461–468.</BibUnstructured>
              </Citation>
              <Citation ID="CR84">
                <CitationNumber>86.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Walther</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Stein</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Viral vectors for gene transfer: a review of their use in the treatment of human diseases</ArticleTitle>
                  <JournalTitle>Drugs</JournalTitle>
                  <VolumeID>60</VolumeID>
                  <FirstPage>249</FirstPage>
                  <LastPage>271</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10983732</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXmslWgtb0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.2165/00003495-200060020-00002</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Walther W, Stein U. Viral vectors for gene transfer: a review of their use in the treatment of human diseases.<Emphasis Type="Italic">Drugs</Emphasis>. 2000;60:249–271.</BibUnstructured>
              </Citation>
              <Citation ID="CR85">
                <CitationNumber>87.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AML</Initials>
                    <FamilyName>Lever</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Gene therapy in the fight against AIDS</ArticleTitle>
                  <JournalTitle>Expert Opinion on Therapeutic Patents</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>161</FirstPage>
                  <LastPage>167</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28Xhslyqtr8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1517/13543776.6.2.161</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lever AML. Gene therapy in the fight against AIDS.<Emphasis Type="Italic">Expert Opinion on Therapeutic Patents</Emphasis>. 1996;6:161–167.</BibUnstructured>
              </Citation>
              <Citation ID="CR86">
                <CitationNumber>88.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Zhao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Kobayashi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Hosokawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Seth</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Adenoviral vectors for cancer gene therapy</ArticleTitle>
                  <JournalTitle>Curr Genomics</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>163</FirstPage>
                  <LastPage>180</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XjvFKgt7o%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.2174/1389202023350516</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zhao W, Kobayashi M, Hosokawa M, Seth P. Adenoviral vectors for cancer gene therapy.<Emphasis Type="Italic">Curr Genomics</Emphasis>. 2002;3:163–180.</BibUnstructured>
              </Citation>
              <Citation ID="CR87">
                <CitationNumber>89.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SJ</Initials>
                    <FamilyName>Hale</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NK</Initials>
                    <FamilyName>Green</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Viral approaches to cancer gene therapy</ArticleTitle>
                  <JournalTitle>Expert Opinion on Therapeutic Patents</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <FirstPage>369</FirstPage>
                  <LastPage>378</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XitFSjurk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1517/13543776.12.3.369</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hale SJ, Green NK. Viral approaches to cancer gene therapy.<Emphasis Type="Italic">Expert Opinion on Therapeutic Patents</Emphasis>. 2002;12:369–378.</BibUnstructured>
              </Citation>
              <Citation ID="CR88">
                <CitationNumber>90.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KJ</Initials>
                    <FamilyName>Garton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Ferri</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EW</Initials>
                    <FamilyName>Raines</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Efficient expression of exogenous genes in primary vascular cells using IRES-based retroviral vectors</ArticleTitle>
                  <JournalTitle>Biotechniques</JournalTitle>
                  <VolumeID>32</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>830</FirstPage>
                  <LastPage>830</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11962605</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XivFGhu7g%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Garton KJ, Ferri N, Raines EW. Efficient expression of exogenous genes in primary vascular cells using IRES-based retroviral vectors.<Emphasis Type="Italic">Biotechniques</Emphasis>. 2002;32(4):830,832,834,836,838,840,842–843.</BibUnstructured>
              </Citation>
              <Citation ID="CR89">
                <CitationNumber>91.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Heider</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SB</Initials>
                    <FamilyName>Verca</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Rusconi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Asmis</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Comparison of lipid-mediated and adenoviral gene transfer in human monocyte-derived macrophages and COS-7 cells</ArticleTitle>
                  <JournalTitle>Biotechniques</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>260</FirstPage>
                  <LastPage>265</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10683735</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXhtFKisrs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Heider H, Verca SB, Rusconi S, Asmis R. Comparison of lipid-mediated and adenoviral gene transfer in human monocyte-derived macrophages and COS-7 cells.<Emphasis Type="Italic">Biotechniques</Emphasis>. 2000;28(2):260–265, 268–270.</BibUnstructured>
              </Citation>
              <Citation ID="CR90">
                <CitationNumber>92.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Kay</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JC</Initials>
                    <FamilyName>Glorioso</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Naldini</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics</ArticleTitle>
                  <JournalTitle>Nat Med.</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>33</FirstPage>
                  <LastPage>40</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11135613</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXmvV2nsw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/83324</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics.<Emphasis Type="Italic">Nat Med.</Emphasis> 2001;7:33–40.</BibUnstructured>
              </Citation>
              <Citation ID="CR91">
                <CitationNumber>93.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Favre</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Provost</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Blouin</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle</ArticleTitle>
                  <JournalTitle>Mol Ther.</JournalTitle>
                  <VolumeID>4</VolumeID>
                  <FirstPage>559</FirstPage>
                  <LastPage>566</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11735340</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XhslOqsL8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/mthe.2001.0494</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Favre D, Provost N, Blouin V, et al. Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle.<Emphasis Type="Italic">Mol Ther.</Emphasis> 2001;4:559–566.</BibUnstructured>
              </Citation>
              <Citation ID="CR92">
                <CitationNumber>94.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TL</Initials>
                    <FamilyName>Timme</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SJ</Initials>
                    <FamilyName>Hall</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Barrios</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SLC</Initials>
                    <FamilyName>Woo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Aguilar-Cordova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TC</Initials>
                    <FamilyName>Thompson</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Local inflammatory response and vector spread after direct intraprostatic injection of a recombinant adenovirus containing the herpes simplex virus thymidine kinase gene and ganciclovir therapy in mice</ArticleTitle>
                  <JournalTitle>Cancer Gene Ther</JournalTitle>
                  <VolumeID>5</VolumeID>
                  <FirstPage>74</FirstPage>
                  <LastPage>82</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9570298</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXisV2rtLc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Timme TL, Hall SJ, Barrios R, Woo SLC, Aguilar-Cordova E, Thompson TC. Local inflammatory response and vector spread after direct intraprostatic injection of a recombinant adenovirus containing the herpes simplex virus thymidine kinase gene and ganciclovir therapy in mice.<Emphasis Type="Italic">Cancer Gene Ther</Emphasis>. 1998;5:74–82.</BibUnstructured>
              </Citation>
              <Citation ID="CR93">
                <CitationNumber>95.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>VR</Initials>
                    <FamilyName>Arruda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Fields</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Milner</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males</ArticleTitle>
                  <JournalTitle>Mol Ther.</JournalTitle>
                  <VolumeID>4</VolumeID>
                  <FirstPage>586</FirstPage>
                  <LastPage>592</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11735343</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XhslOqsLo%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/mthe.2001.0491</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Arruda VR, Fields PA, Milner R, et al. Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males.<Emphasis Type="Italic">Mol Ther.</Emphasis> 2001;4:586–592.</BibUnstructured>
              </Citation>
              <Citation ID="CR94">
                <CitationNumber>96.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Tenenbaum</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Lehtonen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PE</Initials>
                    <FamilyName>Monahan</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Evaluation of risks related to the use of adeno-associated virus-based vectors</ArticleTitle>
                  <JournalTitle>Curr Gene Ther</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>545</FirstPage>
                  <LastPage>565</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14683451</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXptFOgtrs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.2174/1566523034578131</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Tenenbaum L, Lehtonen E, Monahan PE. Evaluation of risks related to the use of adeno-associated virus-based vectors.<Emphasis Type="Italic">Curr Gene Ther</Emphasis>. 2003;3:545–565.</BibUnstructured>
              </Citation>
              <Citation ID="CR95">
                <CitationNumber>97.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TR</Initials>
                    <FamilyName>Flotte</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BL</Initials>
                    <FamilyName>Laube</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Gene therapy in cystic fibrosis</ArticleTitle>
                  <JournalTitle>Chest</JournalTitle>
                  <VolumeID>120</VolumeID>
                  <IssueID>suppl 3</IssueID>
                  <FirstPage>124S</FirstPage>
                  <LastPage>131S</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11555567</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXnt12lsr4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1378/chest.120.3_suppl.124S</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Flotte TR, Laube BL. Gene therapy in cystic fibrosis.<Emphasis Type="Italic">Chest</Emphasis>. 2001;120(suppl 3):124S-131S.</BibUnstructured>
              </Citation>
              <Citation ID="CR96">
                <CitationNumber>98.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SE</Initials>
                    <FamilyName>Raper</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Chirmule</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FS</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer</ArticleTitle>
                  <JournalTitle>Mol Genet Metab</JournalTitle>
                  <VolumeID>80</VolumeID>
                  <IssueID>1–2</IssueID>
                  <FirstPage>148</FirstPage>
                  <LastPage>158</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14567964</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXotVChtrw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ymgme.2003.08.016</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Raper SE, Chirmule N, Lee FS, et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.<Emphasis Type="Italic">Mol Genet Metab</Emphasis>. 2003;80(1–2):148–158.</BibUnstructured>
              </Citation>
              <Citation ID="CR97">
                <CitationNumber>99.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RA</Initials>
                    <FamilyName>Owens</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Second generation adeno-associated virus type 2-based gene therapy systems with the potential for preferential integration into AAVSI</ArticleTitle>
                  <JournalTitle>Curr Gene Ther</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <FirstPage>145</FirstPage>
                  <LastPage>159</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12109212</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XjvFKgsbo%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.2174/1566523024605627</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Owens RA. Second generation adeno-associated virus type 2-based gene therapy systems with the potential for preferential integration into AAVSI.<Emphasis Type="Italic">Curr Gene Ther</Emphasis>. 2002;2:145–159.</BibUnstructured>
              </Citation>
              <Citation ID="CR98">
                <CitationNumber>100.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Nyberg-Hoffman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Aguilar-Cordova</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Instability of adenoviral vectors during transport and its implication for clinical studies</ArticleTitle>
                  <JournalTitle>Nat Med.</JournalTitle>
                  <VolumeID>5</VolumeID>
                  <FirstPage>955</FirstPage>
                  <LastPage>957</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10426323</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXltVyjtro%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/11400</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nyberg-Hoffman C, Aguilar-Cordova E. Instability of adenoviral vectors during transport and its implication for clinical studies.<Emphasis Type="Italic">Nat Med.</Emphasis> 1999;5:955–957.</BibUnstructured>
              </Citation>
              <Citation ID="CR99">
                <CitationNumber>101.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Cao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Mytinger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Huard</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Adenovirus mediated gene transfer to skeletal muscle</ArticleTitle>
                  <JournalTitle>Microsc Res Tech</JournalTitle>
                  <VolumeID>58</VolumeID>
                  <FirstPage>45</FirstPage>
                  <LastPage>51</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12112422</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XlvFWnurY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/jemt.10116</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cao B, Mytinger JR, Huard J. Adenovirus mediated gene transfer to skeletal muscle.<Emphasis Type="Italic">Microsc Res Tech</Emphasis>. 2002;58:45–51.</BibUnstructured>
              </Citation>
              <Citation ID="CR100">
                <CitationNumber>102.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Bachrach</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Pelegrin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Piechaczyk</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FS</Initials>
                    <FamilyName>Pedersen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Duch</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Efficient Gene Transfer into Spleen Cells of Newborn Mice by a Replication-Competent Retroviral Vector</ArticleTitle>
                  <JournalTitle>Virology</JournalTitle>
                  <VolumeID>293</VolumeID>
                  <FirstPage>328</FirstPage>
                  <LastPage>334</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11886253</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XhslemsL4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/viro.2001.1284</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bachrach E, Pelegrin M, Piechaczyk M, Pedersen FS, Duch M. Efficient Gene Transfer into Spleen Cells of Newborn Mice by a Replication-Competent Retroviral Vector.<Emphasis Type="Italic">Virology</Emphasis>. 2002;293:328–334.</BibUnstructured>
              </Citation>
              <Citation ID="CR101">
                <CitationNumber>103.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Fattal</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Delattre</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Dubernet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Couvreur</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Liposomes for the delivery of nucleotides and oligonucleotides</ArticleTitle>
                  <JournalTitle>S.T.P. Pharma Sciences</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <FirstPage>383</FirstPage>
                  <LastPage>390</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXjsFyqtQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fattal E, Delattre J, Dubernet C, Couvreur P. Liposomes for the delivery of nucleotides and oligonucleotides.<Emphasis Type="Italic">S.T.P. Pharma Sciences</Emphasis>. 1999;9:383–390.</BibUnstructured>
              </Citation>
              <Citation ID="CR102">
                <CitationNumber>104.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Fattal</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Dubernet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Couvreur</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Liposome-based formulations for the delivery of oligonucleotides</ArticleTitle>
                  <JournalTitle>S.T.P. Pharma Sciences</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>31</FirstPage>
                  <LastPage>44</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXhvFentrs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fattal E, Dubernet C, Couvreur P. Liposome-based formulations for the delivery of oligonucleotides.<Emphasis Type="Italic">S.T.P. Pharma Sciences</Emphasis>. 2001;11:31–44.</BibUnstructured>
              </Citation>
              <Citation ID="CR103">
                <CitationNumber>105.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MC</Initials>
                    <FamilyName>Pedroso de Lima</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Simoes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Pires</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Faneca</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Duzgunes</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications</ArticleTitle>
                  <JournalTitle>Adv Drug Deliv Rev</JournalTitle>
                  <VolumeID>47</VolumeID>
                  <IssueID>2–3</IssueID>
                  <FirstPage>277</FirstPage>
                  <LastPage>294</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11311996</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXislGlsL8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0169-409X(01)00110-7</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pedroso de Lima MC, Simoes S, Pires P, Faneca H, Duzgunes N. Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications.<Emphasis Type="Italic">Adv Drug Deliv Rev</Emphasis>. 2001;47(2–3):277–294.</BibUnstructured>
              </Citation>
              <Citation ID="CR104">
                <CitationNumber>106.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SJ</Initials>
                    <FamilyName>Hwang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ME</Initials>
                    <FamilyName>Davis</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Cationic polymers for gene delivery: designs for overcoming barriers to systemic administration</ArticleTitle>
                  <JournalTitle>Curr Opin Mol Ther</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>183</FirstPage>
                  <LastPage>191</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11338932</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXjtlKitb0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hwang SJ, Davis ME. Cationic polymers for gene delivery: designs for overcoming barriers to systemic administration.<Emphasis Type="Italic">Curr Opin Mol Ther</Emphasis>. 2001;3:183–191.</BibUnstructured>
              </Citation>
              <Citation ID="CR105">
                <CitationNumber>107.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GF</Initials>
                    <FamilyName>Lemkine</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BA</Initials>
                    <FamilyName>Demeneix</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Polyethylenimines for in vivo gene delivery</ArticleTitle>
                  <JournalTitle>Curr Opin Mol Ther</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>178</FirstPage>
                  <LastPage>182</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11338931</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXjtlKitbw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lemkine GF, Demeneix BA. Polyethylenimines for in vivo gene delivery.<Emphasis Type="Italic">Curr Opin Mol Ther</Emphasis>. 2001;3:178–182.</BibUnstructured>
              </Citation>
              <Citation ID="CR106">
                <CitationNumber>108.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CP</Initials>
                    <FamilyName>Lollo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MG</Initials>
                    <FamilyName>Banaszezyk</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PM</Initials>
                    <FamilyName>Mullen</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Poly-L-lysine-based gene delivery systems: synthesis, purification, and application</ArticleTitle>
                  <JournalTitle>Methods Mol Med.</JournalTitle>
                  <VolumeID>69</VolumeID>
                  <FirstPage>1</FirstPage>
                  <LastPage>13</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11987770</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXoslSqsrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lollo CP, Banaszezyk MG, Mullen PM, et al. Poly-L-lysine-based gene delivery systems: synthesis, purification, and application.<Emphasis Type="Italic">Methods Mol Med.</Emphasis> 2002;69:1–13.</BibUnstructured>
              </Citation>
              <Citation ID="CR107">
                <CitationNumber>109.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Borchard</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Chitosans for gene delivery</ArticleTitle>
                  <JournalTitle>Adv Drug Deliv Rev</JournalTitle>
                  <VolumeID>52</VolumeID>
                  <FirstPage>145</FirstPage>
                  <LastPage>150</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11718938</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXosFKltbY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0169-409X(01)00198-3</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Borchard G. Chitosans for gene delivery.<Emphasis Type="Italic">Adv Drug Deliv Rev</Emphasis>. 2001;52:145–150.</BibUnstructured>
              </Citation>
              <Citation ID="CR108">
                <CitationNumber>110.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JG</Initials>
                    <FamilyName>LeHoux</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Grondin</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Some effects of chitosan on liver function in the rat</ArticleTitle>
                  <JournalTitle>Endocrinology</JournalTitle>
                  <VolumeID>132</VolumeID>
                  <FirstPage>1078</FirstPage>
                  <LastPage>1084</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7679967</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXhvVeiu7o%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1210/en.132.3.1078</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>LeHoux JG, Grondin F. Some effects of chitosan on liver function in the rat.<Emphasis Type="Italic">Endocrinology</Emphasis>. 1993;132:1078–1084.</BibUnstructured>
              </Citation>
              <Citation ID="CR109">
                <CitationNumber>111.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BI</Initials>
                    <FamilyName>Florea</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Meaney</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HE</Initials>
                    <FamilyName>Junginger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Borchard</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and non-differentiated COS-1 cell cultures</ArticleTitle>
                  <JournalTitle>AAPS Pharm Sci</JournalTitle>
                  <VolumeID>4</VolumeID>
                  <IssueID>3</IssueID>
                  <FirstPage>E12</FirstPage>
                  <LastPage>E12</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1208/ps040312</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Florea BI, Meaney C, Junginger HE, Borchard G. Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and non-differentiated COS-1 cell cultures.<Emphasis Type="Italic">AAPS Pharm Sci</Emphasis>. 2002;4(3):E12.</BibUnstructured>
              </Citation>
              <Citation ID="CR110">
                <CitationNumber>112.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Koping-Hoggard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Tubulekas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Guan</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo</ArticleTitle>
                  <JournalTitle>Gene Ther</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>1108</FirstPage>
                  <LastPage>1121</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11526458</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXlt1antbc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.gt.3301492</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Koping-Hoggard M, Tubulekas I, Guan H, et al. Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo.<Emphasis Type="Italic">Gene Ther</Emphasis>. 2001;8:1108–1121.</BibUnstructured>
              </Citation>
              <Citation ID="CR111">
                <CitationNumber>113.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>WT</Initials>
                    <FamilyName>Godbey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AG</Initials>
                    <FamilyName>Mikos</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Recent progress in gene delivery using non-viral transfer complexes</ArticleTitle>
                  <JournalTitle>J Control Release</JournalTitle>
                  <VolumeID>72</VolumeID>
                  <IssueID>1–3</IssueID>
                  <FirstPage>115</FirstPage>
                  <LastPage>125</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11389990</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXktVGksrk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0168-3659(01)00267-X</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Godbey WT, Mikos AG. Recent progress in gene delivery using non-viral transfer complexes.<Emphasis Type="Italic">J Control Release</Emphasis>. 2001;72(1–3):115–125.</BibUnstructured>
              </Citation>
              <Citation ID="CR112">
                <CitationNumber>114.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Petersen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PM</Initials>
                    <FamilyName>Fechner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Fischer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Kissel</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Synthesis, characterization, and biocompatibility of polyethylenimine-graft-poly(ethylene glycol) block copolymers</ArticleTitle>
                  <JournalTitle>Macromolecules</JournalTitle>
                  <VolumeID>35</VolumeID>
                  <FirstPage>6867</FirstPage>
                  <LastPage>6874</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XlsVCgurw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/ma012060a</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Petersen H, Fechner PM, Fischer D, Kissel T. Synthesis, characterization, and biocompatibility of polyethylenimine-graft-poly(ethylene glycol) block copolymers.<Emphasis Type="Italic">Macromolecules</Emphasis>. 2002;35:6867–6874.</BibUnstructured>
              </Citation>
              <Citation ID="CR113">
                <CitationNumber>115.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Leclercq</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Dubertret</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Pitard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Scherman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Herscovici</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Synthesis of glycosylated polyethylenimine with reduced toxicity and high transfecting efficiency</ArticleTitle>
                  <JournalTitle>Bioorg Med Chem Lett</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>1233</FirstPage>
                  <LastPage>1235</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10866388</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXktF2qtLw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0960-894X(00)00195-5</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Leclercq F, Dubertret C, Pitard B, Scherman D, Herscovici J. Synthesis of glycosylated polyethylenimine with reduced toxicity and high transfecting efficiency.<Emphasis Type="Italic">Bioorg Med Chem Lett</Emphasis>. 2000;10:1233–1235.</BibUnstructured>
              </Citation>
              <Citation ID="CR114">
                <CitationNumber>116.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Akinc</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Langer</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Measuring the pH environment of DNA delivered using nonviral vectors: implications for lysosomal trafficking</ArticleTitle>
                  <JournalTitle>Biotechnol Bioeng</JournalTitle>
                  <VolumeID>78</VolumeID>
                  <FirstPage>503</FirstPage>
                  <LastPage>508</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12115119</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XjvV2mtLY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/bit.20215</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Akinc A, Langer R. Measuring the pH environment of DNA delivered using nonviral vectors: implications for lysosomal trafficking.<Emphasis Type="Italic">Biotechnol Bioeng</Emphasis>. 2002;78:503–508.</BibUnstructured>
              </Citation>
              <Citation ID="CR115">
                <CitationNumber>117.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Mumper</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SL</Initials>
                    <FamilyName>Klakamp</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Polymeric gene delivery systems for in vivo gene therapy</ArticleTitle>
                  <JournalTitle>Drug Targeting and Delivery</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>143</FirstPage>
                  <LastPage>173</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXns1ClsLc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mumper RJ, Klakamp SL. Polymeric gene delivery systems for in vivo gene therapy.<Emphasis Type="Italic">Drug Targeting and Delivery</Emphasis>. 1999;10(Advanced Gene Delivery):143–173.</BibUnstructured>
              </Citation>
              <Citation ID="CR116">
                <CitationNumber>118.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CM</Initials>
                    <FamilyName>Ward</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Pechar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Oupicky</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Ulbrich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LW</Initials>
                    <FamilyName>Seymour</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate-mediated targeting in vitro and prolonged plasma circulation in vivo</ArticleTitle>
                  <JournalTitle>J Gene Med</JournalTitle>
                  <VolumeID>4</VolumeID>
                  <FirstPage>536</FirstPage>
                  <LastPage>547</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12221647</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XosVWru74%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/jgm.296</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ward CM, Pechar M, Oupicky D, Ulbrich K, Seymour LW. Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate-mediated targeting in vitro and prolonged plasma circulation in vivo.<Emphasis Type="Italic">J Gene Med</Emphasis>. 2002;4:536–547.</BibUnstructured>
              </Citation>
              <Citation ID="CR117">
                <CitationNumber>119.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Jeong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TG</Initials>
                    <FamilyName>Park</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Poly(l-lysine)-g-poly(d,l-lactic-co-glycolic acid) micelles for low cytotoxic biodegradable gene delivery carriers</ArticleTitle>
                  <JournalTitle>J Control Release</JournalTitle>
                  <VolumeID>82</VolumeID>
                  <FirstPage>159</FirstPage>
                  <LastPage>166</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12106986</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XltVOlurY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0168-3659(02)00131-1</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jeong JH, Park TG. Poly(l-lysine)-g-poly(d,l-lactic-co-glycolic acid) micelles for low cytotoxic biodegradable gene delivery carriers.<Emphasis Type="Italic">J Control Release</Emphasis>. 2002;82:159–166.</BibUnstructured>
              </Citation>
              <Citation ID="CR118">
                <CitationNumber>120.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Wolfert</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LW</Initials>
                    <FamilyName>Seymour</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Chloroquine and amphipathic peptide helixes show synergistic transfection in vitro</ArticleTitle>
                  <JournalTitle>Gene Ther</JournalTitle>
                  <VolumeID>5</VolumeID>
                  <FirstPage>409</FirstPage>
                  <LastPage>414</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9614562</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXhslyjsLY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.gt.3300606</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wolfert MA, Seymour LW. Chloroquine and amphipathic peptide helixes show synergistic transfection in vitro.<Emphasis Type="Italic">Gene Ther</Emphasis>. 1998;5:409–414.</BibUnstructured>
              </Citation>
              <Citation ID="CR119">
                <CitationNumber>121.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AK</Initials>
                    <FamilyName>Singla</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Chawla</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Chitosan: some pharmaceutical and biological aspects-an update</ArticleTitle>
                  <JournalTitle>J Pharm Pharmacol</JournalTitle>
                  <VolumeID>53</VolumeID>
                  <FirstPage>1047</FirstPage>
                  <LastPage>1067</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11518015</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXmvVylsb4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1211/0022357011776441</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Singla AK, Chawla M. Chitosan: some pharmaceutical and biological aspects-an update.<Emphasis Type="Italic">J Pharm Pharmacol</Emphasis>. 2001;53:1047–1067.</BibUnstructured>
              </Citation>
              <Citation ID="CR120">
                <CitationNumber>122.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Kawamata</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Nagayama</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Nakao</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Receptor-independent augmentation of adenovirus-mediated gene transfer with chitosan in vitro</ArticleTitle>
                  <JournalTitle>Biomaterials</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <FirstPage>4573</FirstPage>
                  <LastPage>4579</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12322978</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XmsVeqsrg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0142-9612(02)00203-X</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kawamata Y, Nagayama Y, Nakao K, et al. Receptor-independent augmentation of adenovirus-mediated gene transfer with chitosan in vitro.<Emphasis Type="Italic">Biomaterials</Emphasis>. 2002;23:4573–4579.</BibUnstructured>
              </Citation>
              <Citation ID="CR121">
                <CitationNumber>123.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Z</Initials>
                    <FamilyName>Cui</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Mumper</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Chitosan-based nanoparticles for topical genetic immunization</ArticleTitle>
                  <JournalTitle>J Control Release</JournalTitle>
                  <VolumeID>75</VolumeID>
                  <FirstPage>409</FirstPage>
                  <LastPage>419</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11489327</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXlsFKisrg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0168-3659(01)00407-2</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cui Z, Mumper RJ. Chitosan-based nanoparticles for topical genetic immunization.<Emphasis Type="Italic">J Control Release</Emphasis>. 2001;75:409–419.</BibUnstructured>
              </Citation>
              <Citation ID="CR122">
                <CitationNumber>124.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Roy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H-Q</Initials>
                    <FamilyName>Mao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SK</Initials>
                    <FamilyName>Huang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KW</Initials>
                    <FamilyName>Leong</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Oral gene delivery with chitosan-DNA nanoparticles generates immunological protection in a murine model of peanut allergy</ArticleTitle>
                  <JournalTitle>Nat Med</JournalTitle>
                  <VolumeID>5</VolumeID>
                  <FirstPage>387</FirstPage>
                  <LastPage>391</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10202926</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXisFOlsr0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/7385</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Roy K, Mao H-Q, Huang SK, Leong KW. Oral gene delivery with chitosan-DNA nanoparticles generates immunological protection in a murine model of peanut allergy.<Emphasis Type="Italic">Nat Med</Emphasis>. 1999;5:387–391.</BibUnstructured>
              </Citation>
              <Citation ID="CR123">
                <CitationNumber>125.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Gitsov</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KR</Initials>
                    <FamilyName>Lambrych</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Dendrimers: synthesis and applications</ArticleTitle>
                  <JournalTitle>Microspheres, Microcapsules &amp; Liposomes</JournalTitle>
                  <VolumeID>5</VolumeID>
                  <FirstPage>31</FirstPage>
                  <LastPage>68</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xmt12lsL0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gitsov I, Lambrych KR. Dendrimers: synthesis and applications.<Emphasis Type="Italic">Microspheres, Microcapsules &amp; Liposomes</Emphasis>. 2002;5(Dendrimers, Assemblies, Nanocomposites):31–68.</BibUnstructured>
              </Citation>
              <Citation ID="CR124">
                <CitationNumber>126.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Eichman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AU</Initials>
                    <FamilyName>Bielinska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JF</Initials>
                    <FamilyName>Kukowska-Latallo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Baker</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">The use of PAMAM dendrimers in the efficient transfer of genetic material into cells</ArticleTitle>
                  <JournalTitle>Pharm Sci Technol Today</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>232</FirstPage>
                  <LastPage>245</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10884679</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXltVKjsLk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S1461-5347(00)00273-X</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Eichman JD, Bielinska AU, Kukowska-Latallo JF, Baker JR, Jr. The use of PAMAM dendrimers in the efficient transfer of genetic material into cells.<Emphasis Type="Italic">Pharm Sci Technol Today</Emphasis>. 2000;3:232–245.</BibUnstructured>
              </Citation>
              <Citation ID="CR125">
                <CitationNumber>127.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BH</Initials>
                    <FamilyName>Zinselmeyer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SP</Initials>
                    <FamilyName>Mackay</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AG</Initials>
                    <FamilyName>Schatzlein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>IF</Initials>
                    <FamilyName>Uchegbu</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">The lower-generation polypropylenimine dendrimers are effective gene-transfer agents</ArticleTitle>
                  <JournalTitle>Pharm Res</JournalTitle>
                  <VolumeID>19</VolumeID>
                  <FirstPage>960</FirstPage>
                  <LastPage>967</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12180548</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xltl2isLw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1016458104359</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zinselmeyer BH, Mackay SP, Schatzlein AG, Uchegbu IF. The lower-generation polypropylenimine dendrimers are effective gene-transfer agents.<Emphasis Type="Italic">Pharm Res</Emphasis>. 2002;19:960–967.</BibUnstructured>
              </Citation>
              <Citation ID="CR126">
                <CitationNumber>128.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Yoo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RL</Initials>
                    <FamilyName>Juliano</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers</ArticleTitle>
                  <JournalTitle>Nucleic Acids Res</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>4225</FirstPage>
                  <LastPage>4231</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11058121</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXovFKqurg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/nar/28.21.4225</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yoo H, Juliano RL. Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers.<Emphasis Type="Italic">Nucleic Acids Res</Emphasis>. 2000;28:4225–4231.</BibUnstructured>
              </Citation>
              <Citation ID="CR127">
                <CitationNumber>129.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Tejada-Berges</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CO</Initials>
                    <FamilyName>Granai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Gordinier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Gajewski</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Caelyx/Doxil for the treatment of metastatic ovarian and breast cancer</ArticleTitle>
                  <JournalTitle>Expert Rev Anticancer Ther</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <FirstPage>143</FirstPage>
                  <LastPage>150</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12113236</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XjvFWiur4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1586/14737140.2.2.143</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Tejada-Berges T, Granai CO, Gordinier M, Gajewski W. Caelyx/Doxil for the treatment of metastatic ovarian and breast cancer.<Emphasis Type="Italic">Expert Rev Anticancer Ther</Emphasis>. 2002;2:143–150.</BibUnstructured>
              </Citation>
              <Citation ID="CR128">
                <CitationNumber>130.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Marshall</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NS</Initials>
                    <FamilyName>Yew</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SJ</Initials>
                    <FamilyName>Eastman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Jiang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RK</Initials>
                    <FamilyName>Scheule</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Cheng</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ChapterTitle Language="En">Cationic lipid-mediated gene delivery to the airways</ChapterTitle>
                  <BibEditorName>
                    <Initials>E</Initials>
                    <FamilyName>Wagner</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Nonviral Vectors for Gene Therapy</BookTitle>
                  <PublisherName>Academic Press</PublisherName>
                  <PublisherLocation>San Diego, CA</PublisherLocation>
                  <FirstPage>39</FirstPage>
                  <LastPage>68</LastPage>
                </BibChapter>
                <BibUnstructured>Marshall J, Yew NS, Eastman SJ, Jiang C, Scheule RK, Cheng SH. Cationic lipid-mediated gene delivery to the airways. In: Wagner E, ed.<Emphasis Type="Italic">Nonviral Vectors for Gene Therapy</Emphasis>. San Diego, CA: Academic Press; 1999;39–68.</BibUnstructured>
              </Citation>
              <Citation ID="CR129">
                <CitationNumber>131.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Felgner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Kumar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CN</Initials>
                    <FamilyName>Sridhar</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations</ArticleTitle>
                  <JournalTitle>J Biol Chem</JournalTitle>
                  <VolumeID>269</VolumeID>
                  <FirstPage>2550</FirstPage>
                  <LastPage>2561</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8300583</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXhsFejsr0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Felgner JH, Kumar R, Sridhar CN, et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1994;269:2550–2561.</BibUnstructured>
              </Citation>
              <Citation ID="CR130">
                <CitationNumber>132.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HEJ</Initials>
                    <FamilyName>Hofland</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Shephard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Sullivan</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Formation of stable cationic lipid/DNA complexes for gene transfer</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>93</VolumeID>
                  <FirstPage>7305</FirstPage>
                  <LastPage>7309</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8692988</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28Xkt1Wgt7g%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.93.14.7305</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hofland HEJ, Shephard L, Sullivan SM. Formation of stable cationic lipid/DNA complexes for gene transfer.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1996;93:7305–7309.</BibUnstructured>
              </Citation>
              <Citation ID="CR131">
                <CitationNumber>133.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S-H</Initials>
                    <FamilyName>Kang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EL</Initials>
                    <FamilyName>Zirbes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Kole</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Delivery of antisense oligonucleotides and plasmid DNA with various carrier agents</ArticleTitle>
                  <JournalTitle>Antisense Nucleic Acid Drug Dev</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <FirstPage>497</FirstPage>
                  <LastPage>505</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10645775</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXktFGguw%3D%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1089/oli.1.1999.9.497</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Kang S-H, Zirbes EL, Kole R. Delivery of antisense oligonucleotides and plasmid DNA with various carrier agents.<Emphasis Type="Italic">Antisense Nucleic Acid Drug Dev</Emphasis>. 1999;9:497–505.</BibUnstructured>
              </Citation>
              <Citation ID="CR132">
                <CitationNumber>134.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Lappalainen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Jaaskelainen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Syrjanen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Urtti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Syrjanen</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Comparison of cell proliferation and toxicity assays using two cationic liposomes</ArticleTitle>
                  <JournalTitle>Pharm Res</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>1127</FirstPage>
                  <LastPage>1131</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7971713</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXlsVWlsLk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1018932714745</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lappalainen K, Jaaskelainen I, Syrjanen K, Urtti A, Syrjanen S. Comparison of cell proliferation and toxicity assays using two cationic liposomes.<Emphasis Type="Italic">Pharm Res</Emphasis>. 1994;11:1127–1131.</BibUnstructured>
              </Citation>
              <Citation ID="CR133">
                <CitationNumber>135.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SD</Initials>
                    <FamilyName>Patil</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DG</Initials>
                    <FamilyName>Rhodes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DJ</Initials>
                    <FamilyName>Burgess</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Anionic liposomal delivery system for DNA transfection</ArticleTitle>
                  <JournalTitle>The AAPS Journal</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>E29</FirstPage>
                  <LastPage>E29</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15760094</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1208/aapsj060429</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Patil SD, Rhodes DG, Burgess DJ. Anionic liposomal delivery system for DNA transfection.<Emphasis Type="Italic">The AAPS Journal</Emphasis>. 2004;6:E29.</BibUnstructured>
              </Citation>
              <Citation ID="CR134">
                <CitationNumber>136.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Dokka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Toledo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>X</Initials>
                    <FamilyName>Shi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Castranova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Rojanasakul</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes</ArticleTitle>
                  <JournalTitle>Pharm Res</JournalTitle>
                  <VolumeID>17</VolumeID>
                  <FirstPage>521</FirstPage>
                  <LastPage>525</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10888302</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXksVGqtbc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1007504613351</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dokka S, Toledo D, Shi X, Castranova V, Rojanasakul Y. Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes.<Emphasis Type="Italic">Pharm Res</Emphasis>. 2000;17:521–525.</BibUnstructured>
              </Citation>
              <Citation ID="CR135">
                <CitationNumber>137.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MC</Initials>
                    <FamilyName>Filion</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NC</Initials>
                    <FamilyName>Phillips</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells</ArticleTitle>
                  <JournalTitle>Biochim Biophys Acta</JournalTitle>
                  <VolumeID>1329</VolumeID>
                  <FirstPage>345</FirstPage>
                  <LastPage>356</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9371426</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXmtVWhtro%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0005-2736(97)00126-0</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Filion MC, Phillips NC. Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells.<Emphasis Type="Italic">Biochim Biophys Acta</Emphasis>. 1997;1329:345–356.</BibUnstructured>
              </Citation>
              <Citation ID="CR136">
                <CitationNumber>138.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BD</Initials>
                    <FamilyName>Freimark</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HP</Initials>
                    <FamilyName>Blezinger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VJ</Initials>
                    <FamilyName>Florack</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>160</VolumeID>
                  <FirstPage>4580</FirstPage>
                  <LastPage>4586</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9574565</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXjtVCqs7g%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Freimark BD, Blezinger HP, Florack VJ, et al. Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes.<Emphasis Type="Italic">J Immunol</Emphasis>. 1998;160:4580–4586.</BibUnstructured>
              </Citation>
              <Citation ID="CR137">
                <CitationNumber>139.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SKR</Initials>
                    <FamilyName>Williams</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SD</Initials>
                    <FamilyName>Allison</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TJ</Initials>
                    <FamilyName>Anchordoquy</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Analysis of self-assembled cationic lipid-DNA gene carrier complexes using flow field-flow fractionation and light scattering</ArticleTitle>
                  <JournalTitle>Anal Chem</JournalTitle>
                  <VolumeID>73</VolumeID>
                  <FirstPage>837</FirstPage>
                  <LastPage>843</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11248901</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXksVyjug%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/ac000831n</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lee H, Williams SKR, Allison SD, Anchordoquy TJ. Analysis of self-assembled cationic lipid-DNA gene carrier complexes using flow field-flow fractionation and light scattering.<Emphasis Type="Italic">Anal Chem</Emphasis>. 2001;73:837–843.</BibUnstructured>
              </Citation>
              <Citation ID="CR138">
                <CitationNumber>140.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Audouy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Molema</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Leij</FamilyName>
                    <Particle>De</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Hoekstra</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Serum as a modulator of lipoplex-mediated gene transfection: dependence of amphiphile, cell type and complex stability</ArticleTitle>
                  <JournalTitle>J Gene Med</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <FirstPage>465</FirstPage>
                  <LastPage>476</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11199267</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xlt1yqurg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/1521-2254(200011/12)2:6&lt;465::AID-JGM141&gt;3.0.CO;2-Z</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Audouy S, Molema G, De Leij L, Hoekstra D. Serum as a modulator of lipoplex-mediated gene transfection: dependence of amphiphile, cell type and complex stability.<Emphasis Type="Italic">J Gene Med</Emphasis>. 2000;2:465–476.</BibUnstructured>
              </Citation>
              <Citation ID="CR139">
                <CitationNumber>141.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Liu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Qi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Huang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Liu</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration</ArticleTitle>
                  <JournalTitle>Gene Ther</JournalTitle>
                  <VolumeID>4</VolumeID>
                  <FirstPage>517</FirstPage>
                  <LastPage>523</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9231067</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXjvFWiu7k%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.gt.3300424</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Liu F, Qi H, Huang L, Liu D. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration.<Emphasis Type="Italic">Gene Ther</Emphasis>. 1997;4:517–523.</BibUnstructured>
              </Citation>
              <Citation ID="CR140">
                <CitationNumber>142.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CJ</Initials>
                    <FamilyName>Wheeler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PL</Initials>
                    <FamilyName>Felgner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>YJ</Initials>
                    <FamilyName>Tsai</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>93</VolumeID>
                  <FirstPage>11454</FirstPage>
                  <LastPage>11459</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8876156</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28Xmtlagsbo%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.93.21.11454</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wheeler CJ, Felgner PL, Tsai YJ, et al. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1996;93:11454–11459.</BibUnstructured>
              </Citation>
              <Citation ID="CR141">
                <CitationNumber>143.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Fillion</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Desjardins</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Sayasith</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Lagace</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Encapsulation of DNA in negatively charged liposomes and inhibition of bacterial gene expression with fluid liposome-encapsulated antisense oligonucleotides</ArticleTitle>
                  <JournalTitle>Biochim Biophys Acta</JournalTitle>
                  <VolumeID>1515</VolumeID>
                  <FirstPage>44</FirstPage>
                  <LastPage>54</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11597351</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXnsVSmtLw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0005-2736(01)00392-3</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fillion P, Desjardins A, Sayasith K, Lagace J. Encapsulation of DNA in negatively charged liposomes and inhibition of bacterial gene expression with fluid liposome-encapsulated antisense oligonucleotides.<Emphasis Type="Italic">Biochim Biophys Acta</Emphasis>. 2001;1515:44–54.</BibUnstructured>
              </Citation>
              <Citation ID="CR142">
                <CitationNumber>144.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Lakkaraju</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Dubinsky</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WC</Initials>
                    <FamilyName>Low</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y-E</Initials>
                    <FamilyName>Rahman</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Neurons are protected from excitotoxic death by p53 antisense oligonucleotides delivered in anionic liposomes</ArticleTitle>
                  <JournalTitle>J Biol Chem</JournalTitle>
                  <VolumeID>276</VolumeID>
                  <FirstPage>32000</FirstPage>
                  <LastPage>32007</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11406618</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXms1Smtrc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1074/jbc.M100138200</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lakkaraju A, Dubinsky JM, Low WC, Rahman Y-E. Neurons are protected from excitotoxic death by p53 antisense oligonucleotides delivered in anionic liposomes.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2001;276:32000–32007.</BibUnstructured>
              </Citation>
              <Citation ID="CR143">
                <CitationNumber>145.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SD</Initials>
                    <FamilyName>Patil</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DG</Initials>
                    <FamilyName>Rhodes</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Conformation of oligodeoxynucleotides associated with anionic liposomes</ArticleTitle>
                  <JournalTitle>Nucleic Acids Res</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>4125</FirstPage>
                  <LastPage>4129</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11058108</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXovFKqs7o%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/nar/28.21.4125</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Patil SD, Rhodes DG. Conformation of oligodeoxynucleotides associated with anionic liposomes.<Emphasis Type="Italic">Nucleic Acids Res</Emphasis>. 2000;28:4125–4129.</BibUnstructured>
              </Citation>
              <Citation ID="CR144">
                <CitationNumber>146.</CitationNumber>
                <BibUnstructured>Patil SD, Rhodes DG, Burgess DJ. Biophysical characterization of anionic lipoplexes<Emphasis Type="Italic">Biochim Biophys Acta.-Biomembranes</Emphasis>. 2005; In Press.</BibUnstructured>
              </Citation>
              <Citation ID="CR145">
                <CitationNumber>147.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Huang</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Lipidic vector systems for gene transfer</ArticleTitle>
                  <JournalTitle>Crit Rev Ther Drug Carrier Syst</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <FirstPage>173</FirstPage>
                  <LastPage>206</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9107521</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXislGjtro%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1615/CritRevTherDrugCarrierSyst.v14.i2.30</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Lee RJ, Huang L. Lipidic vector systems for gene transfer.<Emphasis Type="Italic">Crit Rev Ther Drug Carrier Syst</Emphasis>. 1997;14:173–206.</BibUnstructured>
              </Citation>
              <Citation ID="CR146">
                <CitationNumber>148.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Guo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Gosselin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Characterization of a novel diolein-based LPDII vector for gene delivery</ArticleTitle>
                  <JournalTitle>J Control Release</JournalTitle>
                  <VolumeID>83</VolumeID>
                  <FirstPage>121</FirstPage>
                  <LastPage>132</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12220844</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XmslKqsL8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0168-3659(02)00167-0</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Guo W, Gosselin MA, Lee RJ. Characterization of a novel diolein-based LPDII vector for gene delivery.<Emphasis Type="Italic">J Control Release</Emphasis>. 2002;83:121–132.</BibUnstructured>
              </Citation>
              <Citation ID="CR147">
                <CitationNumber>149.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Perrie</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Gregoriadis</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Liposome-entrapped plasmid DNA: characterization studies</ArticleTitle>
                  <JournalTitle>Biochim Biophys Acta</JournalTitle>
                  <VolumeID>1475</VolumeID>
                  <FirstPage>125</FirstPage>
                  <LastPage>132</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10832026</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXjs1Cit70%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Perrie Y, Gregoriadis G. Liposome-entrapped plasmid DNA: characterization studies.<Emphasis Type="Italic">Biochim Biophys Acta</Emphasis>. 2000;1475:125–132.</BibUnstructured>
              </Citation>
              <Citation ID="CR148">
                <CitationNumber>150.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Venugopalan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Jain</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Sankar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Singh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Rawat</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SP</Initials>
                    <FamilyName>Vyas</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">pH-Sensitive liposomes: mechanism of triggered release to drug and gene delivery prospects</ArticleTitle>
                  <JournalTitle>Pharmazie</JournalTitle>
                  <VolumeID>57</VolumeID>
                  <FirstPage>659</FirstPage>
                  <LastPage>671</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12426945</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XosVKqurs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Venugopalan P, Jain S, Sankar S, Singh P, Rawat A, Vyas SP. pH-Sensitive liposomes: mechanism of triggered release to drug and gene delivery prospects.<Emphasis Type="Italic">Pharmazie</Emphasis>. 2002;57:659–671.</BibUnstructured>
              </Citation>
              <Citation ID="CR149">
                <CitationNumber>151.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AL</Initials>
                    <FamilyName>Maclean</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Symonds</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Ward</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Immunoliposomes as targeted delivery vehicles for cancer therapeutics (Review)</ArticleTitle>
                  <JournalTitle>Int J Oncol</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>325</FirstPage>
                  <LastPage>332</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXlt1Ggsb0%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.3892/ijo.11.2.325</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Maclean AL, Symonds G, Ward R. Immunoliposomes as targeted delivery vehicles for cancer therapeutics (Review).<Emphasis Type="Italic">Int J Oncol</Emphasis>. 1997;11:325–332.</BibUnstructured>
              </Citation>
              <Citation ID="CR150">
                <CitationNumber>152.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JY</Initials>
                    <FamilyName>Legendre</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FC</Initials>
                    <FamilyName>Szoka</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes</ArticleTitle>
                  <JournalTitle>Pharm Res</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <FirstPage>1235</FirstPage>
                  <LastPage>1242</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1448419</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK38Xmtl2lu7c%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1015836829670</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Legendre JY, Szoka FC Jr. Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes.<Emphasis Type="Italic">Pharm Res</Emphasis>. 1992;9:1235–1242.</BibUnstructured>
              </Citation>
              <Citation ID="CR151">
                <CitationNumber>153.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Reddy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Low</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation</ArticleTitle>
                  <JournalTitle>J Control Release</JournalTitle>
                  <VolumeID>64</VolumeID>
                  <IssueID>1–3</IssueID>
                  <FirstPage>27</FirstPage>
                  <LastPage>37</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10640643</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXks1Gmtw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0168-3659(99)00135-2</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Reddy JA, Low PS. Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation.<Emphasis Type="Italic">J Control Release</Emphasis>. 2000;64(1–3):27–37.</BibUnstructured>
              </Citation>
              <Citation ID="CR152">
                <CitationNumber>154.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>YV</Initials>
                    <FamilyName>Sviridov</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RI</Initials>
                    <FamilyName>Zhdanov</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>OV</Initials>
                    <FamilyName>Podobed</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TA</Initials>
                    <FamilyName>Tsvetkova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Konstantinov</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EV</Initials>
                    <FamilyName>Bogdanenko</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">The LacZ gene transfer into L929 cells and [14C]-DNA tissue distribution following intraperitoneal administration of new pH-sensitive lipoplexes in mice</ArticleTitle>
                  <JournalTitle>Cytobios</JournalTitle>
                  <VolumeID>106</VolumeID>
                  <IssueID>suppl 1</IssueID>
                  <FirstPage>7</FirstPage>
                  <LastPage>14</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11534831</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXntVaju7k%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sviridov YV, Zhdanov RI, Podobed OV, Tsvetkova TA, Konstantinov I, Bogdanenko EV. The LacZ gene transfer into L929 cells and [14C]-DNA tissue distribution following intraperitoneal administration of new pH-sensitive lipoplexes in mice.<Emphasis Type="Italic">Cytobios</Emphasis>. 2001;106:(suppl 1), 7–14.</BibUnstructured>
              </Citation>
              <Citation ID="CR153">
                <CitationNumber>155.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Xu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C-C</Initials>
                    <FamilyName>Huang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Huang</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes</ArticleTitle>
                  <JournalTitle>Mol Cancer Ther</JournalTitle>
                  <VolumeID>1</VolumeID>
                  <FirstPage>337</FirstPage>
                  <LastPage>346</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12489850</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XjtFWms74%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Xu L, Huang C-C, Huang W, et al. Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes.<Emphasis Type="Italic">Mol Cancer Ther</Emphasis>. 2002;1:337–346.</BibUnstructured>
              </Citation>
              <Citation ID="CR154">
                <CitationNumber>156.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Shi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Zhu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Boado</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WM</Initials>
                    <FamilyName>Pardridge</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Brain-specific expression of an exogenous gene after IV administration</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>98</VolumeID>
                  <FirstPage>12754</FirstPage>
                  <LastPage>12759</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11592987</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXotFahs7w%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.221450098</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Shi N, Zhang Y, Zhu C, Boado RJ, Pardridge WM. Brain-specific expression of an exogenous gene after IV administration.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2001;98:12754–12759.</BibUnstructured>
              </Citation>
              <Citation ID="CR155">
                <CitationNumber>157.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BA</Initials>
                    <FamilyName>Khaw</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Silva</FamilyName>
                    <Particle>da</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Vural</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Narula</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VP</Initials>
                    <FamilyName>Torchilin</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Intracytoplasmic gene delivery for in vitro transfection with cytoskeleton-specific immunoliposomes</ArticleTitle>
                  <JournalTitle>J Control Release</JournalTitle>
                  <VolumeID>75</VolumeID>
                  <IssueID>1–2</IssueID>
                  <FirstPage>199</FirstPage>
                  <LastPage>210</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11451510</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXkvFyit74%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0168-3659(01)00364-9</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Khaw BA, da Silva J, Vural I, Narula J, Torchilin VP. Intracytoplasmic gene delivery for in vitro transfection with cytoskeleton-specific immunoliposomes.<Emphasis Type="Italic">J Control Release</Emphasis>. 2001;75(1–2):199–210.</BibUnstructured>
              </Citation>
              <Citation ID="CR156">
                <CitationNumber>158.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>WC</Initials>
                    <FamilyName>Krauss</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Park</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DB</Initials>
                    <FamilyName>Kirpotin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Hong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CC</Initials>
                    <FamilyName>Benz</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Emerging antibody-based HER2 (ErbB-2/neu) therapeutics</ArticleTitle>
                  <JournalTitle>Breast Disease</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>113</FirstPage>
                  <LastPage>124</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15687597</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXmsVSitrs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Krauss WC, Park JW, Kirpotin DB, Hong K, Benz CC. Emerging antibody-based HER2 (ErbB-2/neu) therapeutics.<Emphasis Type="Italic">Breast Disease</Emphasis>. 2000;11:113–124.</BibUnstructured>
              </Citation>
              <Citation ID="CR157">
                <CitationNumber>159.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Mannisto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Vanderkerken</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Toncheva</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Structure-activity relationships of poly(l-lysines): effects of pegylation and molecular shape on physicochemical and biological properties in gene delivery</ArticleTitle>
                  <JournalTitle>J Control Release</JournalTitle>
                  <VolumeID>83</VolumeID>
                  <FirstPage>169</FirstPage>
                  <LastPage>182</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12220848</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XmslKqt70%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0168-3659(02)00178-5</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mannisto M, Vanderkerken S, Toncheva V, et al. Structure-activity relationships of poly(l-lysines): effects of pegylation and molecular shape on physicochemical and biological properties in gene delivery.<Emphasis Type="Italic">J Control Release</Emphasis>. 2002;83:169–182.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
